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Abstract
Almost a decade has passed ever since the first time nanoparticles were proposed to
be used for tumor/cancer diagnosis and treatment. For tumor/cancer treatments,
nanoparticles are usually engineered to be the photo-thermal agent to promote the
selectivity of the photo-thermal therapy while the most promising diagnostic applica-
tion for nanoparticles might be being used as the exogenous optical contrast agent for
optical imaging technique. This study is targeted at developing numerical modeling
& simulation to be a subsidiary tool of experimental investigation of diagnostic &
therapeutic applications of nanoparticles, particularly, gold-silica nanoshells. Around
this goal, the present study is comprised with four sub-projects, each would be pre-
sented as an independent chapter.
Firstly, an alternative method for calculating the spatial distribution of inter-
stitial fluence rate in laser-induced interstitial thermo-therapy is introduced. The
method originates from the un-simplified integral-diﬀerential radiant transport equa-
tion, which is then solved by the radial basis function collocation technique. Vali-
dation of the method against the stochastic Monte Carlo and the numerical finite
volume method has been done. Secondly, the nanoparticle assisted laser-induced
interstitial thermo-therapy for tumor/cancer treatments is numerically investigated,
which was targeted at exploring the therapeutic eﬀects of a variety of treatment
conditions including laser wavelength, power, exposure time, concentrations of tai-
i
lored nanoparticles, and optical/thermal properties of the tissue that is under the
treatment. Thirdly, the feasibility of extending nanoparticle assisted photo-thermal
therapy from treating subcutaneous tumors to treating organ tumors, particularly,
tumors growing in the clearance organ liver has been investigated. For organ tumors,
nanoparticles could not recognize tumors from the surrounding normal organ tissue
very well, as what has been for subcutaneous tumors. And last, how gold-silica
nanoshells alter the diﬀuse reflectance signature of tissue phantoms has been numer-
ically investigated, for the purpose of exploring how to engineering nanoshells to be
good exogenous optical contrast agent for early-staged cancer diagnostic imaging.
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1Introduction
Almost a decade has passed ever since the first time nanoparticles were proposed to
be used for tumor/cancer diagnosis and treatment. For tumor/cancer treatments,
nanoparticles are usually engineered to be the photo-thermal agent to promote the
selectivity of the photo-thermal therapy while the most promising diagnostic applica-
tion for nanoparticles might be being used as the exogenous optical contrast agent for
optical imaging technique. This study is targeted at developing numerical modeling
& simulation to be a subsidiary tool of experimental investigation of diagnostic &
therapeutic applications of nanoparticles, particularly, gold-silica nanoshells. Around
this goal, the study was comprised with four sub-projects, each would be listed as
an independent chapter in the following up text, in which more details about the
projects could be found. Here, a brief summary is given:
In chapter 2, an alternative method for calculating the spatial distribution of
interstitial fluence rate in laser-induced interstitial thermotherapy(LITT) is intro-
duced. The method originates from the un-simplified integral-diﬀerential radiant
transport equation, which is then solved by the radial basis function collocation
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technique. After comparing with the Monte Carlo and finite volume methods, it is
concluded that this method is able to provide accurate predictions of fluence rate
distributions along the penetration depth, particularly around the boundary.
In chapter 3, phantom based nanoparticle assisted laser-induced interstitial ther-
motherapy process for tumor/cancer treatments has been numerically investigated.
The goal of this investigation is to explore the therapeutic eﬀects of a variety of
treatment conditions including laser wavelength, power, exposure time, concentra-
tions of tailored nanoparticles, and optical/thermal properties of the tissue that is
under the treatment. It is found that using absorbing preferential nanoparticles as
the photo-thermal agent would weaken fluence rate distributions in terms of lowering
fluence rate peaks and reducing the laser penetration depth. However, the local en-
hancement in absorption induced by nanoparticles is so significant that the reduced
fluence rate will not only be balanced out but the eventual medical hyperthermia is
greatly enhanced by using nanoparticles. Also, the results of numerical simulations
indicate that with constant laser illumination, an increase in nanoparticle concentra-
tion beyond a certain range only has an insignificant impact on hyperthermia.
In chapter 4, the feasibility of extending nanoparticle assisted photothermal ther-
apy (PPTT) from treating subcutaneous tumors to treating organ tumors, partic-
ularly, tumors growing in the clearance organ liver, has been numerically explored.
A superficially embedded liver tumor and its immediate surrounding medium is se-
lected as the study object. The tumor is externally irradiated by a 633nm laser
beam of the intensity 1 ´ W {cm2 .The matching [16, 21] nm gold-silica nanoshell
with a 16´nm silica core and a 5´nm thick gold shell is used as the photothermal
agent. The nanoshell retention ratio is varied to simulate diﬀerent levels of nanoshell
tumor discriminations. Laser light distributions, conversions from the photon energy
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to heat and thermal responses of the tissues to the generated heat within the study
object are analyzed. It is found that although nanoshells have enhanced the thermal
transportation, they at the same time refrain the optical transportation of PPTT,
indicating that PPTT is more demanding for laser delivery techniques compared to
convention laser therapy. For the investigated case, when the nanoshell retention
ratio is in the range of 2{1 4{1, the therapeutic eﬀects is optimal: a confined medium
temperature hyperthermia p47´ 55˝Cq is achieved in the liver tumor while impacts
on the surrounding health liver tissues are only marginal; When then nanoshell re-
tention ratio is 8{1 or higher, about half of the liver tumor is ablated. However, part
of the surrounding healthy liver tissue is sacrificed as well. PPTT therapeutic eﬀects
nonlinearly depends on the nanoshell tumor discriminations, better tumor discrimi-
nations does not necessarily result in better PPTT therapeutic eﬀects.
Finally in chapter 5, how gold-silica nanoshells alter the diﬀuse reflectance signa-
ture of tissue phantoms has been investigated, for the purpose of exploring how to
engineering nanoshells to be good exogenous optical contrast agent for early-staged
cancer diagnostic imaging. Seven generics of nanoshells with diﬀerent overall size and
ratio of core radius-to-gold shell thickness are tested. Two of these generics are pref-
erentially absorbing and the rest are preferentially scattering. Three phantom models
have been used, including: (a) The laser lights directly illuminate the precancerous
tissue bulk with nanoshells embedded within; (b) The precancerous tissue bulk is
enclosed from the outside by the normal tissue bulk. Nanoshells are confined wholly
in the precancerous tissue bulk; (c) the layout is the same as (b),but nanoshells are
found in both the precancerous tissue bulk and the enclosing normal tissues bulk,
with the nanoshell concentration in the normal tissue bulk ten times lower. The
simulation results show that the all seven generics of nanoshells diminish the diﬀuse
reflectance signature of the phantoms, at diﬀerent levels. It is analyzed and argued
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that whether a generic of nanoshell would augment or diminish the diﬀuse reflectance
signature depends on whether the overall scattering albedo of the tissue medium is
increased or decreased after the addition of nanoshells. Nanoshells whose scattering
dominates the extinction spectrum are as capable of diminish the diﬀuse reflectance
signature as nanoshells whose absorption dominates the extinction spectrum. It was
also found that for all three phantom models, nanoshells could alter the diﬀuse re-
flectance signature significantly as long as suﬃcient amount of nanoshells could be
deposited in the precancerous tissue bulk. Particularly, the diﬀuse reflectance sig-
nature in phantom (c) is altered the most while the diﬀuse reflectance signature in
phantom (a) is altered the least, when same amount of same generic nanoshells are
embedded.
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2Modeling fLuence rae distribution in laser-induced
interstitial thermotherapy by meshfree collocation
2.1 Introduction
The laser-induced interstitial thermo-therapy ( LITT ) is a minimally invasive treat-
ment of deeply embedded cancers/tumors (1). During the treatment, the diﬀusing
laser applicator is placed inside the cancer tissues/tumors for a period of time that
lasts from minutes to tens of minutes. The goal of LITT is to “ burn out” tar-
geted cancerous tissues/tumors while minimizing the lasers’ impact on surrounding
healthy tissues and structures such as nerves and blood vessels. Because of potential
damages to surrounding healthy tissues, accurate predictions of spatial distribution
of laser fluence rate, laser energy absorption and subsequently, thermal response of
biological tissues to the absorbed laser energy are crucial.
The first stage of LITT simulation is optical modeling, namely, the computation
of spatial distributions of fluence rate and laser energy absorption. The second stage
is bio-heat modeling, which simulates biological tissues’ thermal responses to the ab-
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sorbed laser energy. For optical modeling, the Monte Carlo method (2; 3; 4) and the
diﬀusion approximation (5) are two most commonly used tools. The Monte Carlo
method is well known for its accuracy and flexibility handling complex computa-
tion geometry, though, the method’s merits have been weakened by its prohibitively
computation time cost, which actually prevents the method from becoming an ideal
tool for clinical real-time usage. Particularly, if the Monte Carlo method is used for
the optical modeling, because of the statistical nature of this method, extra work is
usually required to bridge the optical modeling and bioheat modeling, which gen-
erally is handled by numerical techniques such as finite diﬀerence method (FDM ),
finite volume method ( FVM ) or finite element method ( FEM ). On the other
hand, approximations such as diﬀusion approximation, P1 approximation and delta-
P1 (6; 7; 8; 9; 10) are eﬃcient in terms of computation time however, at the sacrifice
of computation accuracy.
In this chapter, a new alternative to compute spatial distribution of interstitial
laser fluence rate in LITT besides Monte Carlo and the mentioned approximations
is brought forward. The proposed method starts form the un-simplified integro-
diﬀerential radiative transfer equation ( RTE ) (11), which is the mathematical
equivalence of Monte Carlo method. The RTE is then solved using the radial basis
function collocation method, a technique which could be easily extended to bio-heat
modeling. During the past decade, it has been more and more realized that mesh
free techniques, with its many branches (12; 13; 14; 15; 16; 17; 18; 19; 20) maybe
be more competent when handling problems that involves discontinuities, irregular
geometry, large deformations and moving boundaries compared to the more tradi-
tional FDM, FVM and FEM. Particular to biomedicine research, this very technique
has been tried in diﬀerent aspects including biomedical imaging (18), medical image
restoration (19), surgery plan optimization (20) and so on. In this chapter, this
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technique’s potential applications in laser therapy plan and real time monitor are
exploited.
2.2 Mathematical formulation

Figure 2.1: Layout of LITT experiment
The performing of LITT is achieved by placing fibers/diﬀusing applicators in-
side cancer tissues/tumors. According to Roggan et al (21), typical in LITT tumor
treatment, lasers of the power of 3´ 10 Watts irradiate for a period of 10´ 20 min-
utes. And Nd: YAG laser p1064nmq or diode lasers p800´ 980nmq are most oftenly
adopted as LITT laser sources.
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The characteristics of fibers/applicators determine how the laser power would be
applied to biological tissues (21). On the surface of the fiber/applicator, radiant
intensity Lpr, sq obeys the law of Fresnel reflection and after laser beam leaves the
surface of the applicator and emits into the biological tissue, Lpr, sq is comprised with
two parts: (1) the remnant of collimation irradiance Lcpr, sq , and (ii) the diﬀusion
radiant intensity Ldpr, sq , which is induced by the collimation irradiance Lcpr, sq:
Lpr, sq “ Lcpr, sq ` Ldpr, sq (2.1)
The distribution of Lcpr, sq within the tissue is governed by the equation:
s ¨￿Lcpr, sq “ ´pkα ` ksqLcpr, sq (2.2)
Meanwhile is subjected to the boundary condition:
Lcpr, sq “ r1´Rspsq0δps´ scq (2.3)
where kα and ks are absorption coeﬃcient and scattering coeﬃcient of the tissue
individually, Rsp is the Fresnel specular reflection(1) and q0 is the laser power.
The distribution of Ldpr, sq is governed by the integro-diﬀerential radiant trans-
port equation (RTE) (22):
dLdpr, sq
ds
“ ´pkα ` ksqLdpr, sq ` ks
4π
ż
4π
Φps, s1qLdpr, s1qdω ` Scpr, sq (2.4)
and is subjected to the following boundary conditions:
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Ldpr “ 1, z P r´dc, dcs, sq
“ Lcpr “ 1, z P r´dc, dcsqδrs´ scs ` Rd
π
ż
n¨s1ă0
Ldpr “ 1, z P r´dc, dcs, s1q |n ¨ s1| dω1
(2.5)
Ldpr “ 1, z R r´dc, dcs, sq “ Rd
π
ż
n¨s1ă0
Ldpr “ 1, z R r´dc, dcs, s1q |n ¨ s1| dω1 (2.6)
Ldpr “ R, z, sq “ Rd
π
ż
n¨s1ă0
Ldpr “ R, z, s1q |n ¨ s1| dω1 (2.7)
Ldpr, z “ |Z| , sq “ Rd
π
ż
n¨s1ă0
Ldpr, z “ |Z| , s1q |n ¨ s1| dω1 (2.8)
where r is the radial position, z is the axial position pr “ pr, zqq, dc is the half
width of the laser beam, R is the radius of the phantom cylinder, and Z is the
half-length of the phantom cylinder, Rd is the reflectivity of the biological tissue,
Φps, s1q is the phase function, for turbid medium such as most biological tissues,
the Henyey-Greenstein function (22) has most frequently been used to represent the
phase function, and Scpr, sq is the source term induced by collimation:
Scpr, sq “ ks
4π
ż
4π
Φps, scqLcdωc (2.9)
At any location within the tissue phantom, the interstitial fluence rate Ψprq can
be computed by integrating Lpr, sq over the space of solid angle:
Ψprq “
ż
4π
Lpr, sqdω “
ż
4π
rLcpr, sq ` Ldpr, sqsdω (2.10)
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Solving Eqs. 2.2 and 2.3 to get Lcpr, sq is straightforward but numerical tech-
niques are necessary to solve Eqs. 2.4, 2.5, 2.6, 2.7 and 2.8 to get Ldpr, sq.
Under cylindrical coordinate, Eq.2.4 can be rewrote into the discrete form (2):
µ
r
B
Br prLdq´
1
r
B
Bψ pηLdq`ξ
BLd
Bz `pkα`ksqLd “
ks
4π
ż
4π
LdΦps, s1qdω1` ks
4π
ż
4π
LcΦps, scqdωc
(2.11)
here sc indicates the direction of collimation and µ, η and ξ are directional cosines:
µ “ sinpθqcospψq
η “ sinpθqsinpψq
ξ “ cospθq
and θ and ψ are polar angle and azimuthal angle, respectively.
The central diﬀerence scheme is applied for the ψ derivative in Eq. 2.11, repre-
senting it in terms of the quadrature weights (w and w1), and the term coeﬃcient
(α) as
B
Bψ pηLdq |ψ“ψi«
αi` 12Ld,i`1 ´ αi´ 12Ld,i´1
2wi1
(2.12)
for i “ 1, 2, ....N
here the subscript i is the index of discrete direction.
Eqs. 2.11, 2.5, 2.6, 2.7 and 2.8 are re-written below where the numerical quadra-
tures replace the integral:
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for i “ 1, 2, .......N
µi
r
Ld,i`µiBLd,iBr ´
αi` 12Ld,i`1 ´ αi´ 12Ld,i´1
2rwi1
`pkα`ksqLd,i “ ks
4π
Nÿ
i1“1,i1‰i
Ld,i1Φi,i1wi1` ks
4π
LcΦic,iwic
(2.13)
Ldpr “ 1, z P r´dc, dcs, sq “ Lcpr “ 1, z P r´dc, dcsqδrs´ scs`
Rd
π
ÿ
n¨s1ă0
wi1Ld,i1pr “ 1, z P r´dc, dcs, s1q |n ¨ s1|
(2.14)
Ldpr “ 1, z R r´dc, dcs, sq “ Rd
π
ÿ
n¨s1ă0
wi1Ld,i1pr “ 1, z R r´dc, dcs, s1q |n ¨ s1| (2.15)
Ldpr “ R, z, sq “ Rd
π
ÿ
n¨s1ă0
wi1Ld,i1pr “ R, z, s1q |n ¨ s1| (2.16)
Ldpr, z “ |Z| , sq “ Rd
π
ÿ
n¨s1ă0
wi1Ld,i1pr, z “ |Z| , s1q |n ¨ s1| (2.17)
Term coeﬃcient αi` 12 and αi´ 12 in Eqs.2.13 obey the following recursion formula:
αi` 12 ´ αi´ 12 “ 2wi1µi (2.18)
α 1
2
“ αN` 12 “ 0 (2.19)
for i “ 1, 2, .....N
2.3 Radial basis function collocation technique
In this section, it is demonstrated how radial basis function collocation methods
could be applied to solve Eqs. 2.13, 2.14, 2.15,2.16 and 2.17. Firstly, rewrite Eqs.
2.13 , 2.14, 2.15, 2.16 and 2.17 in terms of operators:
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LiLd,ipr, zq “ fi (2.20)
BiLd,ipr, zq “ gi, (2.21)
for i “ 1, 2, .......N
where Li and Bi are operators defined as
Li “ µi
r
` µi BBr ` ξi
B
Bz ` pkα ` ksq (2.22)
Bi “ 1 (2.23)
The force functions fi and gi in Eqs.2.20 and 2.21 are individually defined as
fi “ ks
4π
Nÿ
i1“1,i1‰i
Ld,i1Φi1,iwi1 ` ks
4π
LicΦic,iwic `
αi` 12Ld,i`1 ´ αi´ 12Ld,i´1
2rwi1
(2.24)
gi “ Lcpr “ 1, z P r´dc, dcsqδps´scq`Rd
π
ÿ
n¨s1ă0
wi1Ld,i1pr “ 1, z P r´dc, dcs, s1q |n ¨ s1| (2.25)
gi “ Rd
π
ÿ
n¨s1ă0
wi1Ld,i1pr “ 1, z R r´dc, dcs, s1q |n ¨ s1| (2.26)
gi “ Rd
π
ÿ
n¨s1ă0
wi1Ld,i1pr “ R, z, s1q |n ¨ s1| (2.27)
gi “ Rd
π
ÿ
n¨s1ă0
wi1Ld,i1pr, z “ |Z| , s1q |n ¨ s1| (2.28)
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Iterations are necessary to compute Eqs. 2.20 and 2.21, Ld,i`1 and Ld,i´1 in the
third term on the RHS of Eq. 2.24 is evaluated based on results generated from the
previous iteration.
According to (23; 24; 25) the approximate solution of Eqs. 2.20 and 2.21 can be
written in the form of:
Lˆd,ipr, z, cq “
K`KBÿ
j“1
λjϕp}r´ ξj} , cq (2.29)
where λ “ rλ1,λ2, ......,λK ,λK`1, .....,λK`KB s is the vector of unknown coeﬃ-
cients that needs to be determined, }r´ ξj} is the distance matrix, which is deter-
mined by positions of collocation points r “ pr, zq and positions of collocation centers
ξ “ pξ1, ξ2q . For 2D cylindrical problems, both collocation points and collocation
centers are defined by their radial and axial positions. In Eq. 2.29, ϕp}¨}q represents
the radial basis function and c is its shape parameter (26; 27), K is the number of
collocation centers, including both centers that are laid out in the interior domain
I and those that are laid out on the boundaries B, KB is the number of “extra”
collocation centers that are laid out of the computation domain for the purpose of
minimizing the boundary residual errors.
Collocate Eqs. 2.20 and 2.21 on all the collocation points, the resulting collocation
matrix is:
pA˜Liqij “ Liϕp}ri ´ ξj} , cq (2.30)
ri P IŤB, ξj P Ξ
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pA˜Bqij “ ϕp}ri ´ ξj} , cq (2.31)
ri P B, ξj P Ξ
where I
Ť
B is the set of collocation point while Ξ is the set of collocation centers.
Consequently, the matrix form of Eqs.2.20 and 2.21 is:
„
A˜Li
A˜B

rλs “
ˆ
fi
gi
˙
(2.32)
The most commonly used radial basis functions include the multiquadric radial
basis function (RBF-MQ), the inverse multiquadric radial basis function (RBF-IMQ),
the Gaussian radial basis function, the thin plate spline radial basis function (TPS-
RBF), Wendland’s compactly support radial basis functions (CSRBF), and Wu’s
compactly support radial basis function. For present work, the Gaussian radial basis
function is adopted as the basis function:
ϕjprq “ e´pc}r´ξj}q2 (2.33)
Consequently, elements of the matrix in Eq.2.32 can be computed according to:
Liϕp}r´ ξ} , cq “ Liϕpr, cq “ Liϕpr, z, cq “ Lie´pcrq2
“ e´pcrq2rpka ` ks ´ ksφi,i
4π
q ` µic
2
2r
´ 2µic2pr ´ ξ1q ´ 2ηic2pz ´ ξ2qs
(2.34)
Substitute Eq.2.34 into Eq.2.32 to achieve the coeﬃcient vector λ. Then, replace
the vector of collocation point r in Eq.2.29 with the vector of evaluation points r˚,
and the solution at the evaluation positions can therefore be reached. The following
are steps to follow when applying this technique to solve the RTE:
Step 1: Compute direction cosines ξ , η and µ and prepare sets for collocation
points, collocation centers and evaluation points.
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Step 2: Iteration starts. Define initial values for Lˆd,i pi “ 1, 2, ..., Nq for all the
collocation points.
Step 3: Construct collocation matrix according to Eqs. 2.30, 2.31, and 2.34.
Construct force functions fi and gi for all collocation points according to Eqs. 2.24,
2.25, 2.26, 2.27 and 2.28 . If iteration index is 1, Lˆd,i`1 and ˆLd,i´1 in Eq. 2.24 are
determined based on the initial guesses and if iteration index is larger than 1, Lˆd,i`1
and ˆLd,i´1 are from the previous iteration.
Step 4: Collocate according to Eqs. 2.30-2.32 to get the undetermined coeﬃcient
vector λ and then use the newly derived λ to update Lˆd,i , force functions fi and
gi for all the collocation points, following Eqs. 2.29, 2.24, 2.25, 2.26, 2.27 and 2.28
separately. Step 4 literally prepares for the next round of iteration.
Step 5: Use the derived λto update Lˆd,i for all the evaluation points. Compare
the new values of Lˆd,i at evaluation points with those from the previous iteration by
calculating the L2 norm of errors. The iteration is terminated if the norm falls below
the tolerance, otherwise, increase the iteration index by 1 and return to Step 3.
2.4 Results and discussion
The layout of LITT experiment investigated in this paper is presented in Fig. 2.1.
The biological tissue that has been used to make the phantom cylinder is the hu-
man prostate, including both the human prostate in its native state and the human
prostate in the coagulated state. The spatial distributions of interstitial fluence rate
in the LITT experiment have been computed using both the radial basis function
collocation method, and the finite volume method. The generated results are pre-
sented in Figs. 2.2 and 2.3. In both figures, solid lines represent results generated
by the radial basis function collocation method, dashed lines represent results gen-
erated by the finite volume method and circles represent results generated by Monte
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Figure 2.2: Interstitial fluence rate pWcm´2q in the z “ 0 plane for native human
prostate. (a) 1064nm Nd: YAG laser adopted as energy source; (b) 980nm diode
laser adopted as laser source; and (c) 850nm diode laser adopted as laser source.
Results of Monte Carlo method are reconstructed according to data from (21)
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Figure 2.3: Interstitial fluence rate pWcm´2q in the z “ 0 plane for coagulated
human prostate. (a) 1064nm Nd: YAG laser adopted as energy source; (b) 980nm
diode laser adopted as laser source; and (c) 850nm diode laser adopted as laser
source. Results of Monte Carlo method are reconstructed according to data from
(21)
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Carlo method, which is taken from (21). Fig.2.2a shows how the interstitial fluence
rate degrades along the depth direction in the z “ 0 plane within the native stated
prostate phantom. The laser used as illumination is Nd:YAG laser with a wavelength
of 1064nm. For this wavelength, native human prostate has an absorption coeﬃcient
of 0.3cm´1, a scattering coeﬃcient of 80cm´1 and an anisotropy factor of 0.95. Ac-
cording to Fig. 2.2a, results generated by the radial basis function collocation method
agree well with those generated by the Monte Carlo method, except for in the region
where the depth distance is from x “ 7mm to x “ 9mm, the radial basis function
collocation method slightly over-predicts the fluence rate. The region that is within
one mean free path from the surface of the diﬀusion applicator is usually defined as
the near-boundary region, where the widely used diﬀusion approximation is known to
be inaccurate. According to Fig. 2.2a, the radial basis function collocation method
accurately predicts the fluence rate in the near-boundary region. The finite volume
method, however, significantly under-predicts the fluence rate in the near-boundary
region, while it over-predicts the fluence rate beyond the near-boundary region. For
this case, the accuracy of the finite volume method is not very satisfactory.
Replace the Nd:YAG laser p1064nmq with a diode laser of the wavelength 980nm
and repeat the numerical procedures, Fig. 2b shows how interstitial fluence rate
degrades along penetration depth in the z “ 0 plane. For this wavelength, native
human prostate has an absorption coeﬃcient of 0.4cm´1, a scattering coeﬃcient of
90cm´1 and an anisotropy factor of 0.95 (21). According to Fig. 2.2b, the radial
basis function collocation method agrees with the Monte Carlo method even better
compared to Fig. 2.2a. There is no obvious discrepancy between the solid line, rep-
resenting results from the radial basis function collocation method and the circles,
representing results from the Monte Carlo method. Meanwhile, the finite volume
method seems to still under-predict fluence rate in the near-boundary region and
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over-predict fluence rate beyond this region.
Fig. 2.2c shows how the interstitial fluence rate degrades along penetration depth
in the z “ 0 plane when using the diode laser of wavelength 850nm. For this wave-
length, native human prostate has an absorption coeﬃcient of 0.6cm´1, a scattering
coeﬃcient of 100cm´1 and an anisotropy factor of 0.94 (21). For this situation,
results generated by both the radial basis function collocation method and the finite
volume method agree with those generated by the Monte Carlo method, with the
radial basis function collocation method still providing better approximations. The
finite volume method still tends to slightly over-predict the fluence rate, however,
the discrepancy is minimized compared to the previous two cases.
Fig. 2.3 shows how interstitial fluence rate degrades along the penetration depth
in the z “ 0 plane in the coagulated human pros- tate tissue phantom. Fig. 2.3a
corresponds to the situation when Nd:YAG laser with wavelength of 1064nm is used
as the laser source. For this wavelength, coagulated human prostate has an absorp-
tion coeﬃcient of 0.4cm´1 , a scattering coeﬃcient of 180cm´1 and an anisotropy
factor of 0.95 (21). Notice that under the same wavelength, coagulated prostate has
a much larger scattering coeﬃcient than the native prostate, indicating that scat-
tering dominates more in coagulated prostate cylinder will result in stronger back
scattering, and because of this stronger back scattering, in coagulated prostate cylin-
der, a much higher peak fluence rate can be expected: according to Fig. 2.2a, the
peak fluence rate is around 15Wcm´2 while Fig. 2.3a shows the peak fluence rate
is around 23Wcm´2. Fig.2.3a also shows that results generated by the radial basis
function collocation method agree with those generated by the Monte Carlo method
really well: the solid line almost overlap with circles. Finite volume method still
appears to under-predict fluence rate in the near-boundary region, however, beyond
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this region, the finite volume method gives good approximations as well.
Fig. 2. 3b and 2.3c shows how coagulated human prostate responds to diode
lasers of diﬀerent wavelengths. For the wavelength of 980nm, coagulated human
prostate has an absorption coeﬃcient of 0.5cm´1, a scattering coeﬃcient of 190cm´1
and an anisotropy factor of 0.95 (21). while for wavelength of 980nm, coagulated
human prostate has an absorption coeﬃcient of 0.7cm´1, a scattering coeﬃcient of
230cm´1 and an anisotropy factor of 0.94 (21). Both Fig. 2.3b and 2.3c shows
that collocation method agrees with Monte Carlo results better while finite volume
method under-predicts fluence rate in the near-boundary region but give very decent
approximation beyond the near-boundary region. When comparing Figs.2.2 and 2.3,
the radial basis function collocation provides satisfactory approximation for all types
of situations, including the near-boundary region, where other widely used approxi-
mations such as diﬀusion approximation are known to fail to give good predictions.
Similar to the diﬀusion approximation, the finite volume method tends to under-
predict the fluence rate values in the near-boundary region, however, as scattering
becomes more dominate, finite volume method gives better approximations.
2.5 Conclusions
In this chapter, an alternative to accurately calculate spatial distribution of inter-
stitial fluence rate is proposed, which is important for LITT treatment plan. Based
on comparisons against Monte Carlo method and the finite volume method, it is
found that the proposed method is able to provide better accuracy approximations
for all types of situations with less computation resources. Particularly, this method
manages to predict the fluence rate in the near-boundary region accurately, while
other widely used approximation methods such as diﬀusion approximation, P1 ap-
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proximation and delta-P1 approximation are known to be inaccurate.
2.6 Remarks
This chapter is adapted from:
X. Xu, A. Meade, Jr. and Y. Bayazitoglu, “Fluence rate distribution in laser-induced
interstitial thermotherapy by meshfree collocation”, International Journal of Heat
and Mass Transfer 53: 4017-4022, 2010.
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3Numerical investigation of nanoparticle-assisted
laser-induced interstitial thermotherapy toward
tumor and cancer treatments
3.1 Introduction
When applying medical lasers to treat tumors and cancers, in order to promote the
transduction from laser photon energy to thermal energy and particularly, in order
to improve lasers’ discrimination between surrounding healthy tissues and targeted
tumors and cancers, so that this treatment is “ selective ”, photothermal agents are
generally necessary. For the past decade, the organic dye indocyanine green (ICG)
(1) has been used as the photothermal agent, which, unfortunately suﬀers from seri-
ous photo-bleaching. Currently, thanks to the fast development of nano science and
technology, photothermal agents that are potentially much more powerful have been
developed, namely, nano- particles.
Up to now, many types of nanoparticles have been tested as photothermal agents
including nanospheres (2; 3; 4), nanorods (5; 6; 7), nanoshells (8; 9; 10; 11), carbon
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nanotubes (12), and nanocages (13; 14). Among these, gold nanorods and silica- gold
nanoshells have proven to be particularly promising. The primary advantage of these
two types of nanoparticles over the others is the extremely agile tunability of their
optical properties (9), specifically their surface plasmonic resonance (SPR) can be
easily tuned to locate in the near- infrared spectrum (NIR ) (750-1,100 nm), the well
known “ therapeutic optical gateway ”. The nanorods and nanoshells can also be
engineered to display absorption cross sections four to five orders higher than those
of ICG, implying highly eﬃcient NIR light absorption properties. Other advantages
include suﬀering much less from photo- bleaching (15), low toxicity to the human
body (16; 17), possibility of being multifunctional (7), facility of bio- conjugation
and bio-modification (18) ,and so on.
Relevant literature (7) has suggested that nanoparticle- assisted laser therapy be
named as plasmonic photothermal therapy (PPTT), to distinguish it from conven-
tional photo- thermal therapy (PPT) (19). Halas et al. systematically performed
experiments to study the biomedical potential of gold-silica nanoshells (8; 9; 10; 11)
and reported that when using gold-silica nanoshells with a 110´nm thick silica core
and a 10 ´ nm thick gold shell as the photothermal agent, the threshold laser dose
to achieve the desired hyperthermia was reduced by 10 to 25-fold, and the achieved
hyperthermia was so highly conformal that the surrounding healthy tissue was left
intact (8). In their investigation of diagnostic and therapeutic applications of gold
nanorods, El-Sayed et al. also have reported successful achievement of “selective”
photothermal therapy by using certain types of gold nanorods as the photothermal
agent(7).
Though nanoparticles seem to hold considerable potentials, multiple treatment
conditions must be carefully manipulated in order to achieve an eﬀective PPTT
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treatment. Manipulation of treatment conditions, which interact with each other
nonlinearly, include selecting the proper laser wavelength, power and exposure time,
select- ing the proper type, number, and placement of fibers/ applicators, and se-
lecting the type and concentration of nanoparticles. The process of manipulating
the treatment conditions is called a therapy plan, and obviously, reliable preliminary
information would be very helpful in constructing a therapy plan. Numerical mod-
eling using sample phantoms is thought to be a most reliable and eﬃcient way of
gathering such information. Although there are several publications (20; 21; 22; 23)
devoted to numerical modeling PPTT procedures, this field remains scantly explored.
In this chapter, we have numerically investigated phantom- based experiments of
PPTT under diﬀerent conditions. In particular, our work lies in a subfield of PPTT
called nanoparticle-assisted laser-induced interstitial thermotherapy (LITT). LITT
is a minimally invasive treatment for tumors that diﬀers from other types of laser
therapy in that through the treatment procedures, the diﬀusing laser applicator is
placed inside the tumor instead of irradiating from the outside, enabling a more ac-
curate and eﬃcient delivery of energy dose to the targeted site. This characteristic
makes LITT a popular option for well- developed, deeply embedded and relatively
large tumors. In our study, diﬀerent types of human tissues have been used to make
the phantom and treatment conditions have been varied to test their therapeutic ef-
fects. The goal of the investigation is threefold: (i) to numerically test the feasibility
of PPTT, (ii) to investigate the therapeutic eﬀects of diﬀerent treatment conditions,
and thirdly, (iii) to test the usefulness of numerical guidance for a therapy plan.
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!Figure 3.1: Layout of LITT experiment
3.2 Mathematical and computational models
Although most biological tissues are low absorbent to the NIR spectrum, the incu-
bated nanoparticles could be engineered to be intense absorbers of NIR lights. These
particles could possibly convert the laser photon energy to thermal energy and trans-
port (diﬀuse) the thermal heat out to the surrounding medium within hundreds of
picoseconds. Consequently, the numerical simulation of nanoparticle- assisted LITT
can be approached as a two-staged procedure (20; 21; 22; 23), optical followed by
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thermal modeling. The first stage (optical modeling) simulates the optical responses
of biological tissues to laser (usually NIR) exposures by approximating the laser light
(the fluence rate) distribution within the nanoparticle-embedded biological tissues.
In the second stage (thermal modeling), the thermal responses, and consequent dam-
ages of tissues, are simulated by approximating the temperature distribution.
Our phantom-based LITT experiment, consisting of a cylindrical tissue phantom
30mm in length and having a radius of 15mm, is illustrated in Fig. 3.1. A cylin-
drical diﬀusion applicator, with a working length of 20mm and 1 ´ mm radius, is
inserted into the tissue phantom from the left. The laser beams exit the surface of
the diﬀusion applicator along the working length and impinge the tissue medium.
Within the tissue, the radiant intensity Lpr, sq is comprised of two parts: (i)
the remnant of collimation irradiance Lcpr, sq, and (ii) the diﬀusion radiant intensity
Ldpr, sq that is induced by the collimation. The transportation of Ldpr, sq is governed
by the radiant transport equation (24; 25):
dLdpr, sq
ds
` pkαprq ` ksprqqLdpr, sq “ ksprq
4π
ż
4π
Φps, s1qdω1 ` Scpr, sq (3.1)
where r indicates the position and s indicates the direction, kαprq and ksprq are
local absorption and scattering coeﬃcients, respectively, Φps, s1q indicates the scat-
tering phase function [34] and Scpr, sq rWmm´3s indicates the source term induced
by collimated irradiation:
Scpr, sq “ ksprq
4π
ż
4π
Φps, s1qLcpr, s1qdω1 (3.2)
According to Fig. 3.1, Eq. 3.1 is subjected to the following boundary conditions:
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Ldpr “ 1, z P r´10, 10s, sq “
Lcpr “ 1, z P r´10, 10sqδrs´ scs ` Rd
π
ż
n¨s1ă0
Ldpr “ 1, z P r´10, 10s, s1q |n ¨ s1| dω1
(3.3)
Ldpr “ 1, z R r´10, 10s, sq “ Rd
π
ż
n¨s1ă0
Ldpr “ 1, z R r´10, 10s, s1q |n ¨ s1| dω1 (3.4)
Ldpr “ 15, z, sq “ Rd
π
ż
n¨s1ă0
Ldpr “ 15, z, s1q |n ¨ s1| dω1 (3.5)
Ldpr, z “ ˘15, sq “ Rd
π
ż
n¨s1ă0
Ldpr, z “ ˘15, s1q |n ¨ s1| dω1 (3.6)
where r is the radial position, z is the axial position pr “ pr, zqq and Rd is the
reflectivity of tissue.
According to the Beer-Lambert law, collimated lights decay exponentially as they
propagate through the tissue medium:
Lc “ q0expp´pkα ` ksqrqδps´ scq (3.7)
where q0 indicates the total laser photon flux, sc is the direction of collimated light.
As previously mentioned, when the laser light propagates through nanoparticle-
incubated biological tissues, it is absorbed and scattered not only by the host tissue
but also by the nanoparticles, therefore kα and ks in Eq. 3.1 and Eq. 3.7, are
overall parameters that take into account contributions from both the biological
tissue (20; 21; 22; 23) and the embedded nanoparticles:
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kα “ kα,np ` kα,t (3.8)
ks “ ks,np ` ks,t (3.9)
where the subscript np indicates properties of nanoparticles and the subscript t
indicates properties of the biological tissue. Before PPTT procedures, nanoparti-
cles need to be delivered to the tumor site first, which is usually achieved by direct
injections to blood vessels. Nanoparticles would preferential accumulate on tumor
sites through the blood circulation because of the leaky vasculature characteristics
of tumors.
For spherical nanoparticles such as nanoshells and nanorods, kα,npand ks,np can
be quantified in terms of the absorption eﬃciency Qabs and the scattering eﬃciency
Qsca (20; 21; 22):
kα,np “ πr20QabsNT (3.10)
ksca,np “ πr20QscaNT (3.11)
where NT is the number of nanoparticles per unit volume, for nanoshells r0 indi-
cates the radius of the core and for nanorods r0 indicates the eﬀective radius, Qabs
and Qsca could be computed using Mie theory (26; 27; 28).
Numerical tools are generally necessary to solve Eq. 3.1 and Eqs.3.3 - 3.6. Under
cylindrical coordinate system, the discrete form of the Eq. 3.1 is:
µ
r
B
Br prLdq ´
1
r
B
BΨpηLdq ` ξ
BLd
Bz ` pkα ` ksqLd “
ks
4π
ż
4π
LdΦps, s1qdω1 ` Sc (3.12)
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where directional cosines µ , η, and ξ can be represented using polar angle θand
azimuthal angle ψ:
µ “ sinpθqcospψq (3.13)
η “ sinpθqsinpψq (3.14)
ξ “ cospθq (3.15)
The central diﬀerence scheme was applied to the derivative of ψ in Eq. 3.12,
and the integrals in Eqs.3.3 - 3.6 and Eq. 3.12 were approximated by numerical
quadratures. The resulting equations are well suited to numerical techniques such
as the finite volume method:
µi
r
Ld,i ` µiBLd,iBr ´
αi` 12Ld,i`1 ´ αi´ 12Ld,i´1
2rwi1
` ξiBLd,iBz ` pkα ` ksqLd,i “
ks
4π
Nÿ
i1“1,i1‰i
Ld,i1Φi1,iwi1 ` ks
4π
LcΦic,iwic
(3.16)
For i=1,2......N
Ldpr “ 1, z P r´10, 10s, sq “ Lcpr “ 1, z P r´10, 10sqδrs´ scs`
Rd
π
ÿ
n¨s1ă0
wi1Ld,i1pr “ 1, z P r´10, 10s, s1q |n ¨ s1|
(3.17)
Ldpr “ 1, z R r´10, 10s, sq “ Rd
π
ÿ
n¨s1ă0
wi1Ld,i1pr “ 1, z R r´10, 10s, s1q |n ¨ s1| (3.18)
Ldpr “ 15, z, sq “ Rd
π
ÿ
n¨s1ă0
wi1Ld,i1pr “ 15, z, s1q |n ¨ s1| (3.19)
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Ldpr, z “ ˘15, sq “ Rd
π
ÿ
n¨s1ă0
wi1Ld,i1pr, z “ ˘15, s1q |n ¨ s1| (3.20)
Term coeﬃcients αi` 12 and αi´ 12 in Eq. 3.16 obey the following recursion formula:
αi` 12 ´ αi´ 12 “ 2wi1µi (3.21)
α 1
2
“ αN` 12 “ 0 (3.22)
With the solution of Eqs. 3.16 -3.20, the distribution of Ldpr, sq can be determined
and the local fluence rate Ψprq can then be computed through integration of the
directional radiant intensity Lpr, sq over the whole solid space:
Ψprq “
ż
4π
Lpr, sqdω “
ż
4π
rLdpr, sq ` Lcpr, sqsdω (3.23)
However, the information that needs to be passed from optical to thermal model-
ing is thermal energy, which is transduced from laser photo energy, and theoretically
can be computed as:
Qsprq “ kαprqΨprq (3.24)
Later, Qsprq will show as the source term in the bio-heat transportation equation.
As previously indicated, when nanoparticles are used as the photothermal agent,
the incubated nanoparticles work as point-wise photon absorbers, converting the
photon energy into heat and diﬀusing it out to its surrounding medium within hun-
dreds of picoseconds. Generally, it has been agreed that from the macro perspective,
the bio-heat equation is still applicable for describing this process and can be written
in cylindrical coordinate system as:
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ρc
BT pr, tq
Bt “
1
r
B
Br prk
BT pr, tq
Br q`
B
Bz pk
BT pr, tq
Bz q´vBpT pr, tq´TArterialq`Qsprq (3.25)
where t corresponds to the time, ρ, c, and k correspond to the density, specific
heat, and thermal conductivity of the medium, respectively, T corresponds to the
temperature, vB indicates the rate of blood perfusion, and Qsprq is the heat source
term that has been computed in optical modeling.
At the boundaries, the tissue phantom is assumed to be cooled by natural con-
vection:
k
BT
Br |r“15“ hpT ´ T8q (3.26)
k
BT
Bz |z“˘15“ hpT ´ T8q (3.27)
where h indicates the convention coeﬃcient and T8 indicates temperature of the
environment.
3.3 Results and discussion
Table 3.1: Optical properties of types of human tissues under diﬀerent wavelengths
Tissues Wavelength(nm) Abs coef(1/mm) Sca coef(1/mm) Sca albedo Anisotropy(g)
prostate 850 0.4 10 0.9615 0.92
breast 633 0.02 39.4 0.9955 0.9
brain 633 0.026 5.7 0.9995 0.9
As previously discussed, treatment eﬀects of PPTT procedures nonlinearly de-
pend on multiple treatment conditions. In order to investigate this dependence,
hyperthermia temperature distributions were simulated for various combinations of
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treatment conditions.
Through this study, the laser power is fixed to be 1W with a resulting colli-
mated radiant intensity of 0.8Wcm´2 emitting from the applicator surface. The
other treatment conditions were varied: two diﬀerent lasers have been used, one is
a diode laser with a wavelength of 850nm and the other is a diode laser with a
wavelength of 633nm. As discussed in the introduction, the laser wavelength must
match the wavelength under which the plasmonic resonance peak of nanoparticles
occurs in order to ensure an eﬃcient treatment. Consequently, two diﬀerent types
of gold-silica nanoshells were selected as the photothermal agent. For the 850nm
diode laser, the silica-gold nanoshell with a silica core of 40nm and a gold shell of
30nm was used(from now on, this type of nanoshell is referred to as the r40, 70snm
nanoshell, with 40nm corresponds to the inner radius of the nanoshell and 70nm
corresponds to the outer radius.
According to (26), the r40, 70snm nanoshell has an absorption cross section
Cabs “ 7.2712E ´ 14 m2 and a scattering cross section Csca “ 6.54408E ´ 15 m2.
The peak of plasmonic resonance of this type of nanoshell occurs at around 843nm.
For the 633´ nm diode laser, a silica-gold nanoshell with a silica core of 16nm and
a gold shell of 5nm was used p from now on, this type of nanoshell is referred to as
the r16, 21snm nanoshell with 16nm corresponds to the inner radius of the nanoshell
and 21nm corresponds to the outer radius. According to (29; 30), the r16, 21snm
nanoshell has an absorption cross section Cabs “ 4.7822E ´ 14 m2 and a scatter-
ing cross section Csca “ 7.47314E ´ 16 m2. The plasmonic resonance peak of the
r16, 21snm nanoshells occurs at around 631nm. To test the relationship between
exposure time and the achieved hyperthermia, the laser illumination time were set
to be 30, 60, and 90s. The concentration values of 0 ml´1, 2E9 ml´1 and 4E9 ml´1
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were tested for both type of nanoshells. Finally, in order to investigate the influences
from host tissues, three diﬀerent types of human tissues have been used to make the
phantom cylinder, including human prostate, human brain, and human breast. The
optical and thermal properties of these tissues can be found in Tables 3.1 and Table
3.2, respectively.
Table 3.2: Thermal properties of types of human tissues
Tissue types Specific heat (J/gK) Heat conductivity (W/Kcm) Density pg{cm3q
Human prostate 3.74 0.00529 1.05
Human breast 3.92 0.00499 0.99
Human brain 3.6 0.00515 1.035
The optical modeling results are shown in Fig. 3.2, Fig.3.3 and Fig.3.4. Figure
3.2 illustrate the results for the human prostate phantom incubated with r40, 70snm
nanoshells and exposed to the 850´nm diode laser. Concentrations of the nanoshells
were set to be 0, 2E9, and 4E9 ml´1. Figure 3.2(left) presents the interstitial flu-
ence rate distribution along the radius in the z “ 0 plane. The figure indicates that
nanoshells prevent the laser light from both diﬀusing out and penetrating deep into
the tissue. The more nanoshells are incubated, the stronger this eﬀect appears to be.
When the phantom is clean of nanoshells, the fluence rate peak is approximately 2.5
Wcm´2, which drops to 1.5 Wcm´2 and 1.2 Wcm´2 when the nanoshell concentra-
tion is increased to 2E9 ml´1 and 4E9 ml´1 , respectively. The physics behind the
results presented in Fig. 3.2(left) is relatively straightforward. As laser light propa-
gates in nanoparticle-incubated tissues, the light is absorbed/scattered by both the
host tissue and the nanoparticles. Since therapeutic nanoparticles are engineered
to be preferentially absorbing, lights extinct before they can actually diﬀuse out or
propagate deeper. When planning a treatment, this calls for caution: NIR lasers
are popular in medicine largely because most biological tissues are low absorbent to
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this spectrum, and this very characteristic enables NIR lights to propagate deep into
the tissue. However, when photothermal agents are used, this advantage is seriously
weakened. This implies that the enhancement in energy transduction is achieved
somehow at the sacrifice of laser penetration depth. Further research is required on
how photon-thermal agents should be manipulated so that the best therapy can be
achieved.
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Figure 3.2: Fluence rate and bioheat distribution along the radius in the z “ 0
plane for the prostate cylinder
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
 Figure 3.3: Fluence rate and bioheat distribution along the radius in the z “ 0
plane for the breast cylinder
The phenomena presented in Fig. 3.2(left) can also be seen for the remaining
two tissues incubated with r16, 21snm nanoshells and illuminated by a 633 ´ nm
laser. Figure 3.3(left) and 3.3(left) present the interstitial fluence rate distributions
along the radius in the z “ 0 plane of the human breast and human brain phantom
respectively. According to Fig. 3.2e, the fluence rate peak is 2.8 Wcm´2 when the
brain phantom is clean of nanoshells, and drops to 1.5 Wcm´2 and 1.2 Wcm´2 when
the concentrations of nanoshells increase to 2E9 ml´1 and 4E9 ml´1 respectively.
With the human breast phantom, Fig. 3.3(left) indicates that the fluence rate
peak drops from 2.5Wcm´2, when clean of nanoshells, to 1.75Wcm´2 and then to 1.5
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 Figure 3.4: Fluence rate and bioheat distribution along the radius in the z “ 0
plane for the brain cylinder
Wcm´2 with the increasing nanoshell concentrations. Fig.3.2(right), Fig.3.3(right),
and Fig.3.4(right) present bio-heat profiles along the radius in the z “ 0 plane within
the human prostate, breast, and brain tissue phantom, respectively. Bio-heat gen-
eration, which is a measure of the transduction between laser photon energy and
thermal heat, can be computed by multiplying the local fluence rate with the local
absorption coeﬃcient. All three figures show that bio-heat profiles develop higher
peak values and steeper slopes with increasing nanoparticle concentrations. This
suggests that transductions from photon energy to thermal energy remain enhanced
despite the fluence rate ineﬃciency.
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If PPTT is to be used in conjunction with other therapies such as radiotherapy
and chemotherapy, the targeted tissue might only need to be heated up to a tem-
perature between 42 and 44 ˝C. However, if PPTT is intended to be an individual
treatment, the targeted tissue needs to be heated up to a higher temperature between
47 and 55 ˝C . Specifically, if ablative tissue damage is intended, targeted tissues
need to be heated up to above 55 ˝C. Whether targeted tissues could be heated up
to the desired temperature within a short period of time is also important for an
eﬀective treatment.
Figure 3.5 presents the temperature distribution along the radius in the z “ 0
plane within the human prostate phantom. According to Fig.3.5, tissue that is free of
nanoparticles can only be heated slowly. For example, after 30s of illumination, the
temperature peak increases to 42 ˝C from the original temperature of 37 ˝C, while
after 90s of illumination, the temperature peak increases further to 46 ˝C. This is
far below the temperature of 55 ˝C, under which ablative tissue damage is suppose
to occur. When nanoshells are incubated into the tissue to a concentration of 2E9
ml´1 , a temperature peak of 47 ˝C is achieved after only 30s of illumination. The
peak climbs to 53 ˝C after 60s of illumination and 57 ˝C after 90s of exposure. The
diameter of the region in which the temperature is above 47 ˝C, after 90s of expo-
sure, is approximately 10mm. With the nanoshell concentration being 4E9 ml´1, a
temperature peak of 50 ˝C is achieved after 30s of illumination. The peak climbs to
illumination and 59 ˝C after 90s of exposure. However, the diameter of the region
in which the temperature is above 47 ˝C actually shrinks slightly when compared to
the 2E9 ml´1 concentration.
Figure 3.6 presents the temperature distribution along the radius in the z “ 0
plane within the brain phantom. A trend similar to that shown in Fig.3.5 is seen.
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Without nanoshells, the temperature peak remains below 50 ˝C after 90s of illumi-
nation. When the incubated nanoshell concentration is 2E9 ml´1 , tissues can be
heated up to be above 55 ˝C in 60s and after 90s of exposure, the diameter of the
region above 47 ˝C is as large as 10mm. Increasing nanoshell concentrations further
to 4E9 ml´1 helps very little promoting the hyperthermia. The temperature peak
increases from 2 to 3 ˝C, while the size of the “hot” region shrinks by approximately
1.5mm.
Figure 3.7 presents the temperature distribution along the radius in the z “ 0
plane of the breast cylinder. Unlike the prostate and brain tissue, the desired hy-
perthermia cannot be achieved in the breast phantom under the present treatment
conditions since the temperature peak climbs to only 47 ˝C, even after 90s of irra-
diance with an incubated nanoshell concentration as high as 4E9 ml´1. To achieve
the desired hyperthermia for this tissue phantom, alternatives include using a higher
laser power, using a diﬀerent laser wavelength, extending the irradiance time, and
increasing the concentration of photothermal agents, must be explored.
Figure 3.8 presents temperature contours in half of the phantoms of human
prostate, brain, and breast, after 90s of illumination and a nanoshell concentration
of 4E9 ml´1. The temperature distributions in the human prostate (Fig. 3.8) and
brain phantom (Fig.3.10) are very similar despite the diﬀerence in the optical prop-
erties of host tissues and nanoparticles incubated as photothermal agents. However,
Fig. 3.9 shows that the induced hyperthermia is much weaker in the breast phantom.
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Figure 3.5: Transitions of temperature distributions along the radius in the z “ 0
plane in the human prostate phantom
3.4 Conclusions
In this chapter, the novel nanoparticle-assisted LITT for tumor/cancer treatments
process was numerically investigated,with the goal of accumulating knowledge and
deepening the understanding of this novel therapy. The whole numerical simulation
has been handled as a two-staged procedure, optical modeling and thermal modeling.
Detailed physical and mathematical models have been used for both stages and the
solutions were approximated by the finite volume technique.
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 Figure 3.6: Transitions of temperature distributions along the radius in the z “ 0
plane in the human brain phantom
In the investigation of the interactions among treatment conditions, numerical
simulations have been produced and results have been presented and analyzed. Based
on our results, the following conclusions were drawn:
1) Incubated nanoparticles prevent laser light from both diﬀusing out and prop-
agating deep into the tissue; the higher the nanoparticle concentration, the more
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Figure 3.7: Transitions of temperature distributions along the radius in the z “ 0
plane in the human breast phantom
significant this eﬀect is. This presents a challenge to deliver laser doses to the tar-
geted site eﬀectively and is worthy of more study;
2) Nanoparticles that are preferentially absorbing would enhance the local trans-
duction from photon energy to thermal energy. The enhancement in local absorption
of photon energy is so significant that ineﬃcient fluence rates will be balanced out.
For all the situations investigated in this study, bioheat generation has been greatly
enhanced by using nanoparticles as the photo- thermal agent;
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Figure 3.8: Temperature distribution after 90s of illumination in half of the human
prostate phantom (nanoshell concentration is 4E9ml´1q
3) The use of a moderate amount of nanoparticles as photothermal agents pro-
motes hyperthermia in that it allows heating the targeted tissue to the desired tem-
perature range in a short period of time. Our simulations indicate that this cannot
be achieved without using nanoparticles, although the other conditions are the same.
However, with constant illumination, an increase in nanoparticle concentration be-
yond a certain range has an insignificant impact on hyperthermia. It is believed
that this work will help determine an optimal level of concentration of photothermal
agents in future therapy.
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Figure 3.9: Temperature distribution after 90s of illumination in half of the human
brain phantom (nanoshell concentration is 4E9ml´1q
3.5 Remarks
This chapter is adapted from:
X. Xu, A. Meade, Jr. and Y. Bayazitoglu, “Numerical Investigation of Nanoparticle
Assisted Laser-induced Interstitial Thermo-therapy for Tumor and Cancer Treat-
ments,” Lasers in Medical Science, 26(2), 213-222, 2011.
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Figure 3.10: Temperature distribution after 90s of illumination in half of the human
breast phantom (nanoshell concentration is 4E9ml´1q
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4Feasibility of selective nanoparticle-assisted
photothermal treatment for an embedded liver
tumor
4.1 Introduction
Up to now, almost all reported in vivo studies of nanoparticle- assisted photother-
mal therapy (PPTT) were conducted on subcutaneous tumors growing immediately
below the skin of live animals (1; 2; 3; 4). For subcutaneous tumors, types of mech-
anisms can induce nanoparticles to bypass the tumors surrounding medium and
preferentially accumulate inside at them. This phenomenon is usually referred to as
the nano- particles selective tumor targeting. Among all the mechanisms, the most
fundamental one is passive accumulation, which is caused by enhanced permeability
and retention eﬀect (ERP). In 1986, ERP was firstly defined by H. Maeda (5) and
has been studied intensely (6; 7; 8; 9) ever since.
Although the feasibility of PPTT on subcutaneous tumors has been repeatedly
confirmed (1; 2; 3; 4; 13) , whether this novel therapy could be pushed further
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to treat organ tumors remains scantly explored. One opinion that popularly exists
among the bio-nano community is that although nanoparticles could intelligently
discriminate a subcutaneous tumor from its surrounding medium, their ability of
discriminating an organ tumor from the surrounding healthy organ tissues is weaker.
Noticeably, many nanoparticles would be retained by the health organ tissues that
surround organ tumors, failing to reach the targeted tumors.
This preceding opinion has been confirmed by many in vivo nanoparticle bio-
distribution studies (1; 4; 10; 11). In a publication which recently appeared,
Goodrich et al. (1) reported that 17 hours after injecting a dose of 14 ˆ 45 nm
gold nanorods (14 nm in radius and 45 nm in length) to the tail veins of live mice,
around 71 percentage of the total injected nanorod dose accumulated in the liver
organ, about 4% of the dose accumulated in the spleen, and about 1 percentage of
the injected dose was found in the kidney and lymph nodes. No substantial amount
of nanorods had been found in other tissue structures and organs, including bones,
lung, kidney, and muscles. In another publication, Li et al. (2) reported that 4
hours after injecting a dose of gold nanoshells with a mean diameter of 43.5 ˘ 2.3
nm and a mean shell thickness of 34 nm to the tail vein of live mice, about 9.2%
of the whole injected nanoparticle dose was found in the clearance organ liver, while
about 5% of the dose was found in the spleen. The kidney and lung tissues retained
12% and 8% of the whole dose, respectively. In theory, the loss of nanoparticles to
the untargeted tissue medium is very unfavorable for PPTT procedures. A direct
consequence might be that the “selectivity” of the therapy, which is the advantage
being boasted of PPTT over conventional photothermal therapy (PTT), would be
impaired. Since systematic experimental studies of extending PPTT to treat organ
tumor are still pending, the present investigation was therefore devoted to numer-
ically explore such possibilities, focusing on the investigation of the achievability
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of “selective” therapeutic eﬀects when nanoparticles tumor recognition is relative
low. The fundamental assumption that the surrounding medium of tumors is clean
of nanoparticles, which has been adopted by almost all published PPTT numerical
simulations (12; 14; 18; 19; 20; 21; 22; 23; 24), was discarded. Diﬀerent situations
of nanoparticles low discrimination between the organ tumor and its surrounding
medium were instead modeled. Particularly, the embedded liver tumor was our re-
search interest here because as the clearance organ, liver tissues have uniquely strong
retention ability to nanoparticles (1; 4). Consequently, treating liver tumors would
be particular challenging for PPTT.
4.2 Mathematical and computational models
The simulation of PPTT procedures can be divided into two stages (18; 19; 20; 21;
22; 23; 24), similar as that of PTT procedures (25; 26). The first stage is opti-
cal simulation, simulating laser light transportations within the biology tissues. The
transportation of laser lights could be described using the radiant transport equation
(RTE). Depending on whether a pulsed laser or a continuous wave laser is used as
the irradiance source, the RTE could either be of the transient form or of the steady
form. The numerical goal for this stage is to approximate the distribution of fluence
rate. The second stage is thermal simulation, simulating the thermal responses of
the biology tissues to the laser exposure. Thermal simulation is governed by the
bio-heat equation (14; 18; 19; 20; 21; 22; 23). The present study adopted the finite
volume method (FVM) for both the optical and bio-heat simulation. The method
was previously used for laser therapy modeling and was validated against the Monte
Carlo simulation and another numerical technique, namely, the meshfree collocation.
Related details could be found in the (27). The same method with necessary mod-
ifications has also been used in another PPTT study and related details could be
found in (15).
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Figure 4.1: The layout of the PPTT experiment ( not up to scale )
Table 4.1: Optical properties for the liver tumor and normal liver tissues
Tissue type λpnmq kλpmm´1q kspmm´1q g ks1pmm´1q δ
Liver tumor 633 0.14 28.0 0.9426 1.51 1.20
Normal liver 633 0.38 28.0 0.952 1.34 0.72
The experiment design for the simulation is presented in Fig. 4.1. The same
experiment design has been used by M. Jode (28) to investigate the selectivity of
photodynamic therapy (PDT). The optical properties of tumor tissues and normal
liver tissues (listed in Table 1) are also found in the same reference. In Fig. 4.1, the
liver tumor was of the shape of a cylinder and was superficially embedded. Except
for the top surface, it was surrounded fully by normal liver tissues. The diameter
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of the tumor was 12 mm and the height was 5mm. A 16mm wide laser beam was
applied from the outside of the tumor to irradiate it. The beam of laser lights was
emitted from a 633-nm heliumneon laser and the intensity of the laser beam was
1 W {cm2. Based on our previous experiences with PPTT tumor treatments (15),
laser irradiance with such an intensity should be strong enough to induce eﬀective
hyperthermia. It could be computed that the volume of the tumor was about 565
mm3. Tumors of such a size are on the small side for the surgery treatment to
be performed very accurately, especially when they fatally grow on the organ liver.
Therefore, treatments such as PPTT and PDT might be more favorable. After laser
lights propagate into the tissue, the lights are absorbed and diﬀused out by the tissue.
The radiant intensity Lpr, sq within the tissues therefore is comprised with two parts:
(1) the remnant of collimation Lcpr, sq and (2) the induced diﬀusion radiant intensity
Ldpr, sq:
Lpr, sq “ Lcpr, sq ` Ldpr, sq (4.1)
According to Beers law, Lcpr, sq could be expressed as the decay of collimation
φ0 :
Lc “ φ0expp´pkαprq ` ksprqqzqδps´ scq (4.2)
where z indicates the penetration depth of the laser, sc indicates the propagating
direction of collimation, φ0 indicates the total laser radiant flux, and kαprq and ksprq
are the local absorption and scattering coeﬃcient, respectively.
The transportation of the diﬀusion radiant intensity Ldpr, sq within the tissue
medium is governed by the RTE:
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BLdpr, s, tq
Bt `
BLdpr, s, tq
Bs `pkαprq`ksprqqLdpr, sq “
ksprq
4π
ż
4π
Φps, s1qLdpr, s1, tqdω1`Scpr, s, tq
(4.3)
Since a continuous waved laser is used as the irradiance, the first term in Eq. 4.3
could be eliminated. In Eq. 4.3, r “ pr, zq is the position vector, s is the direction
vector, Φps, s1q represents the scattering phase function, and Scpr, sq indicates the
source term induced by collimation:
Scpr, sq “ ksprq
4π
ż
4π
Φps, s1qLcpr, s1qdω1 (4.4)
In Eqs. 4.24.4, the absorption coeﬃcient kαprq and the scattering coeﬃcient
ksprq are overall parameters that count contributions from both the host tissue and
embedded nanoparticles (18; 19; 20; 21; 22; 23; 15):
kαprq “ kα,npprq ` kα,tprq (4.5)
ksprq “ ks,npprq ` ks,tprq (4.6)
where the subscript “t” indicates that the corresponding optical properties are for
tissues while the subscript “np” indicates that the corresponding optical properties
are for nanoparticles.
The boundary condition for Eq. 4.3 is tentative. If there is any collimation light
entering from the location rb, the boundary condition is:
Ldprb, sq “ p1´Rspqφ0δrs´ scs ` Rd
π
ż
n¨s1ă0
Ldprb, s1q |n ¨ s1| dω1 (4.7)
otherwise,
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Ldprb, sq “ Rd
π
ż
n¨s1ă0
Ldprb, s1q |n ¨ s1| dω1 (4.8)
where Rsp indicates Fresnel specular reflection and Rd indicates the internal re-
flectivity of local medium.
While Eq. 4.2 gives a direct solution to Lcpr, sq , Ldpr, sq could be approached
by numerically solving Eqs.4.3 and 4.4 and Eqs. 4.7 and 4.8 using FVM.
Many diﬀerent nanostructures have been tested for PPTT, including nanospheres
(2), nanorods (1; 31; 32), nanoshells (33; 34; 35; 36; 3), carbon nanotubes (37), and
nanocages (38; 39). Among them, goldsilica nanoshells and gold nanorods are par-
ticularly promising mainly because their plasmon resonance could be easily tuned
to be located in the near-infrared spectrum and their plasmonic resonance could
be tuned to be four to five orders higher than that of organ dyes (30; 40), which
were used as photo- thermal agent prior to nanoparticles. Other merits of goldsilica
nanoshells and gold nanorods include low toxicity (41; 42), less photobleaching, and
multifunctionality (32? ) such as playing the dual roles of the photothermal agent
and the optical contrast agent.
The goldsilica nanoshell is adopted as the photothermal agent for PPTT pro-
cedures. The silica core of the nanoshell has a radius of 16 nm, and the gold shell
thickness is 5nm. In the following text, this type of nano- shell would be referred to as
the Rr16, 21snm nanoshell. Therapeutic performances of the Rr16, 21snm nanoshells
as the photothermal agent have previously been investigated in studies (15; 18; 19).
Based on the Mie calculation (29), the Rr16, 21snm nanoshells are preferentially
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absorbing, with the absorption cross- section Cabs p4.7822E ´ 14 m2q being almost
two orders higher in magnitude than its scattering cross-section Csca p7.47314E´ 16
m2q. Also, the plasmonic resonance peak of the Rr16, 21snm nanoshell appears at the
wavelength of 631nm , matching perfectly with the wavelength of the laser irradiance.
The absorption and scattering coeﬃcients kα,np and ks,np could be quantified in
terms of the absorption eﬃciency Qabs and scattering eﬃciency Qsca (18; 19; 20; 21;
22; 15):
kα,np “ πr20QabsNT (4.9)
ks,np “ πr20QscaNT (4.10)
NT in Eq. 4.9 is the number of nanoparticles per unit volume (in other terms,
concentration); for spherical structures such as nanoshells, r0 is the core radius; and
for other non-spherical structures, r0 should be the eﬀective radius. The absorp-
tion eﬃciency Qabs and the scattering eﬃciency Qsca were evaluated using Mie series
(29; 30).
In order to simulate diﬀerent discriminations of nano- shells for the liver tumor
and normal liver tissues, values of nanoshell retention ratio (which is defined as the
nanoshell concentration in the targeted tumor versus the nanoshell concentration in
the normal tissue) have been varied from 0 : 0 (corresponding to the situation of
conventional PTT, no photothermal agents used) to 1{1, 2{1, 4{1 , and eventually
to 8{1 . Here “1” corresponds to a concentration of 1E16 shells{m3. The higher the
nanoshell retention value, the better nanoshells recognize the liver tumor from the
surrounding medium.
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Solving Eq. 4.2 to get Lcpr, sq and solving Eqs. 4.3 and Eqs.4.7 to get Ldpr, sq,
then the fluence rate Ψprq can then be computed by integrating the radiant intensity
Lpr, sq over the solid angle space:
Ψprq “
ż
4π
Lpr, sq “
ż
4π
rLcpr, sq ` Ldpr, sqsdω1 (4.11)
Further, the transduction from the photon energy to thermal heat could be eval-
uated as:
Qsprq “ kαprqΨprq (4.12)
Qsprq will appear as the source term in the bio-heat transportation equation.
When exposed to laser irradiance, the embedded nano- shells work point-wisely as
photon absorbers, converting the photon energy into thermal heat within hundreds
of picoseconds and dissipating the generated thermal heat out to their surrounding
medium (12; 14). The time scale of thermal heat generation is many orders smaller
in magnitude compared to the time scale of thermal heat transportation within the
biology tissues, which is controlled by the thermal conductivity of the tissue medium.
Therefore, time elapses for the thermal heat generation can be neglected.
Under the cylindrical coordinate system, the heat transportation equation is:
ρc
BT pr, tq
Bt “
1
r
B
Br prk
T pr, tq
Bz q `
B
Bz pk
BT pr, tq
Bz q ´ vBpT pr, tq ´ TArterialq `Qspr, tq
(4.13)
Where t indicates the time, ρindicates the density of the medium, c indicates
the specific heat of the medium, T corresponds to the temperature, k is the thermal
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conductivity of the medium, and vB is the blood perfusion rate. According to (16),
for both the tumor and healthy liver tissues, the density ρ is 1,090 kg{m3, and the
heat conductivity k is 0.45 W {mK. The specific heat c is 3,400 J{kgK for liver
tumor and 3,370 J{kgK for the healthy liver tissues.
For the layout depicted in Fig. 4.1, the thermal boundary condition could be
described as:
k
BT
Bz |z“0“ hpT ´ T8q (4.14)
Where h represents the convention coeﬃcient and T8 resents the environment
temperature and was set to be 25 ˝C.
4.3 Results and discussion
Based on the mathematical models described in an earlier section, numerical simu-
lations have been run to model the therapeutic eﬀects of the experiment. Results of
the fluence rate distribution, the conversion from photon energy to thermal heat, and
the distribution of hyperthermia temperature within the study object are presented
and discussed in this section.
The optical penetration depth (δ) is an important factor to judge a laser de-
livery procedure. It also provides important information to predict the inducible
hyperthermia. Approximately, for turbid tissue medium, δ could be calculated as
δ “ 13rkα`ksp1´gqs . For the wavelength of 633nm , the liver tumor has an absorption
coeﬃcient of 0.14mm´1 , a scattering coeﬃcient of 28.0mm´1 , and an anisotropy
factor of 0.946 (28); is therefore computed to be 1.2 mm. For the same wavelength,
the absorption, scattering coeﬃcient, and anisotropy factor for the healthy liver tis-
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Figure 4.2: The distribution of the fluence rate pW {cm2q within the study object
p the liver tumor and surrounding normal liver tissues q when a the retention ratio
= 0 : 0, b the retention ratio “ 1{1, c the retention ratio “ 2{1, d the retention ratio
“ 4{1, e the retention ratio “ 8{1
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sue are 0.38 mm´1, 28.0 mm´1, and 0.952, respectively (28). It could be computed
that δ for the healthy liver tissue is 0.72 mm. It is noticed that because of diﬀerences
in optical properties, δ for the liver tumor is almost twice that for the normal liver
tissues, which is therapeutically favorable.
The destruction depth of the exposed tissues nonlinearly depends on the laser
penetration depth δ, the fluence rate distribution (which is also related to δ), the
concentration of embedded nanoparticles, and laser exposure time. Typically, the
tissue destruction depth could be four to five times larger than the optical penetra-
tion depth δ (17). Since the embedded nanoparticles usually impose extra resistances
for laser lights to penetrate deeper, PPTT is more demanding for good laser delivery
techniques compared to PTT.
The transitions of fluence rate distribution with the nano- shell retention ratio
are presented in Fig.4.2. Because of the symmetrical characteristics of the present
problem, only half of the geometry is shown. Figure 4.2a corresponds to the situation
when retention ratio was 0 : 0. According to Fig.4.2a, if no nanoshells were used,
laser lights (in terms of fluence rate) decayed more rapidly in the normal liver tissue
than they did in the liver tumor. The diﬀerences in the optical decay rates within
the two tissues lead to significant distortions of the iso-fluence rate curves at the
junction of the two tissues, the position of which was r0 “ 6mm
Figure 4.2b presents the laser light distribution when the nanoshell retention ratio
was 1 : 1, implying that nanoshells did not recognize the liver tumor from the normal
tissues at all. Figure 4.2b indicates that under this situation, the reduction of δ is
less significant for the normal liver tissue. The analyzed reason is: compared to the
normal liver tissue, the liver tumor has a smaller absorption coeﬃcient; therefore,
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Figure 4.3: The distribution of the thermal heat generation pW {cm2q within the
study object p the tumor and surrounding normal liver tissues q when a the retention
ratio “ 0 : 0, b the retention ratio “ 1{1, c the retention ratio “ 2{1, d the retention
ratio “ 4{1, e the retention ratio “ 8{1
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the extra absorption introduced by nanoshells has a greater aﬀect on the liver tumor.
Because of the diﬀerences of nanoshell impact on the two tissues, distortions of the
iso- fluence rate contours at the junction have been smoothed out compared to what
is presented in Fig. 4.2a.
The nanoshell retention ratio was continuously increased to 2{1, 4{1, and 8{1
to simulate the improving tumor discriminations of nanoshells. The corresponding
fluence rate distributions are presented in Fig. 4.2ce, respectively. It can be seen
that when the nanoshell retention ratio was 4{1, the distortions of the iso-fluence
rate contours on the tissue junction almost disappeared. According to Fig. 4.2d, it
looked like the laser lights propagated in one homogeneous medium instead of two
diﬀerent tissues with very diﬀerent optical properties. When the retention ratio was
increased to 8{1, the laser light decayed faster in the liver tumor than in the normal
liver tissues. The distortions of iso-fluence rate con- tours that disappeared in the
Fig. 4.2d came back, only with the distorted direction changed.
Besides reductions in the penetration depth δ, Fig.4.2ae also shows that the flu-
ence rate peaks dropped consecutively from 2 to 1.4 W {cm2 with the increasing
nanoshell retention ratio. A deep laser penetration and an intensive fluence rate
distribution are both therapeutically desired for PPTT. Yet, Fig. 4.2ae shows that
both have been impaired because of the embedded nanoshells. Optically, PPTT is
in a less favorable position compared to PTT. Is the thermal enhancement induced
by nanoshells strong enough to balance out the optical ineﬃciencies? To answer this
question, the conversion from the photon energy to the thermal heat within the study
object was evaluated and then the temperature distribution was simulated. Figure
4.3a presents the thermal heat generation when no nanoshells have been used. Figure
4.3a shows that relative to what was in the liver tumor, the conversion from laser
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Figure 4.4: The temperature field p˝Cq within the study object after 30s of laser
exposure when a the retention ratio “ 0 : 0, b the retention ratio “ 1{1, c the
retention ratio “ 2{1, d the retention ratio “ 4{1, e the retention ratio “ 8{1
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photon energy to bio-heat was much more intense in the normal tissues. Therefore,
if the irradiance lasts long enough, it is predictable that normal liver tissues will be
destroyed before the liver tumor. Therefore, the conventional PTT is not a feasible
therapy for the present liver tumor case at 633 nm. Even after the nanoshell retention
ratio was increased to 2{1 (corresponding to Fig. 4.3c), the thermal heat generation
in the normal tissues was still stronger. Only after the nanoshell retention ratio was
increased to 4{1 did the thermal heat generation in the tumor start to exceed that
in the normal tissues.
PPTT could either work independently as a primary treatment or work as an
adjuvant tool for other therapies such as surgery and chemotherapy. When applied
as a primary treatment, tumor tissues need to be heated up to a temperature range
of 47 to 55 ˝C. Particularly, if tumor ablation is desired, tumor tissues need to be
heated up to be over 55 ˝C. If PPTT is applied as an adjuvant treatment, a low
hyperthermia of 4143 ˝C is enough to weaken the tumor cells such that the eﬀective-
ness the primary therapy could be significantly enhanced [45]. Whether the targeted
tumor could be heated up to the desired temperature immediately is also a very
important factor to judge the therapeutic eﬀects.
Figures 4.4 and 4.5 present the temperature fields of the study object after expo-
sure for 30 and 90 s, respectively, corresponding to the diﬀerent nanoshell retention
ratio values. It can be seen that if no nanoshells were used (Figs. 4.4a and 4.5a),
after 90 s of laser irradiance, only a narrow banded region in the normal tissue site
has been heated up to the temperature 43 ˝C, while the temperature peak in the
tumor is less than 42 ˝C. Again, the conclusion that conventional PTT is not a fea-
sible therapy for the present liver tumor case at 633 nm was confirmed. If nanoshells
could not recognize the liver tumor from normal liver tissues (consequently, the re-
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Figure 4.5: The temperature field p˝Cq within the study object after 90 s of laser
exposure when a the retention ratio “ 0 : 0, b the retention ration “ 1{1, c the
retention ratio “ 2{1, d the retention ratio “ 4{1, e the retention ratio “ 8{1
69
tention ratio is 1 : 1), the laser was non-selective in its thermally induced therapeutic
eﬀect. When the nanoshell retention ratio was increased to 2{1, after 90 s of laser
irradiance, about one fifth of the entire tumor achieved a temperature that is above
47 ˝C; meanwhile, the temperature peak in the normal liver tissue was still lower
than 43 ˝C. An increasing nanoshell retention ratio corresponds to a better tumor
discrimination of nanoshells. Figures 4.4d and 4.5d shows that when the retention
ratio was as high as 4{1, the achieved therapeutic eﬀects were desirable: around one
third of the whole tumor was heated up to temperatures above 50 ˝C, while the
temperature peak in the normal tissue was lower than 45 ˝C, and only a marginal
region was heated up to such a temperature. If the retention ratio was increased
further to 8{1, after 90 s of exposure (Fig. 4.5e), tumor ablations happened in more
than half of the entire tumor. However, a region in the surrounding normal tissue
suﬀered from serious damages as well. As long as being selective is the major focus,
the therapeutic eﬀect when the nanoshell retention ratio was 8{1 was not as desirable
as that when the retention ratio is 4{1, or even when it was 2{1.
4.4 Conclusions
PPTT is a novel therapy plan that has been repeatedly confirmed as feasible for
subcutaneous tumor treatments. The present investigation numerically explored the
feasibility of extending this therapy further to treat organ tumors, particularly tu-
mors growing in the liver. Based on the simulations, the following conclusions were
drawn:
1. PPTT is more demanding for laser delivery compared to PTT.
2. For the current case of liver tumor at 633 nm, when the nanoshell retention
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ratio was less than 4{1 (with 1 corresponding to a concentration of 1E16 shells{m3),
the intensity of thermal heat generation in normal liver tissues was unfavorably
stronger. The retention ratio value of 4{1 was the turning point, for which the values
of bio-heat generation intensity in the liver tumor and in normal liver tissues were
comparable. Only when the retention ratio was higher than 4{1 did the intensity of
thermal heat generation in the tumor exceed that in normal liver tissues.
3. As long as the “selective” therapeutic eﬀect is the key focus, the therapeutic
eﬀect of PPTT under the nano- shell retention value 8/1 was not better than it was
when the retention ratio was 4{1, or even 2{1 . Our simulations showed that the rela-
tion between the nanoshell tumor discrimination and the PPTT therapeutic eﬀects
was strongly nonlinear. Improving nanoshell tumor recognition does not promise
more selective PPTT therapeutic eﬀects. We therefore suggest that detailed prelimi-
nary numerical simulations should be conducted to gain some insights of therapeutic
eﬀects before a real experimental investigation is performed.
4.5 Remarks
This chapter is adapted from:
X. Xu, A. Meade Jr and Y. Bayazitoglu, “Feasibility of Selective Nanoparticle As-
sisted Photothermal Treatment for an Embedded Liver Tumor,” Lasers in Medical
Science 2012, Accepted and to appear.
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5A numerical investigation of nanoshells as the
exogeneous optical contrast agent for early cancer
diagnosis
5.1 Introduction
In modern medicine, nanoparticles have found applications in both the diagnostic
and therapeutic procedures (1; 2; 3; 4; 5; 6; 7; 8; 9; 10; 11; 12; 13; 14; 15; 16; 17;
18; 19; 20; 21; 22; 23; 24; 25; 26; 27; 28; 29; 30; 31; 32; 33; 34; 35; 36). For ther-
apeutic applications, nanoparticles are usually engineered to be the photo-thermal
agent to promote the selectivity of the photo-thermal therapy. In Chapter 3 and
Chapter 4, such applications have been numerically exploited. The most promising
diagnostic application for nanoparticles might be being used as the exogenous opti-
cal contrast agent for optical imaging technique. The optical imaging technique is
basically a scattering based imaging technique, heavily relying on how laser lights
are absorbed and scattered when they propagate through the object that is being
imaged. Imaging approaches such as the optical confocal microscopy (37; 38; 39),
optical coherence tomography (40; 41; 42; 43) and spectroscopy (44; 45; 46) all fall
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into this category. Compared to other more well-developed imaging modalities such
as magnetic resonance imaging (MRI), radiology and positron emission tomography
(PET), the optical imaging technique is advantageous in that it could capture images
within micrometer resolution, improving the imaging resolutions ever achieved by 1
to 2 orders (43). This merit makes optical imaging approaches stand out among
all the imaging modalities for early-staged cancer detection, particularly because the
disease signature of precancerous tissues is usually too subtle for other alternatives.
The underlying motivation of applying the optical imaging technique to early-
staged cancer diagnosis is that because of the diﬀerences in optical properties of
normal tissues and precancerous tissues, the consequent contrasts in optical signa-
tures could possibly be captured. Attracted by this idea, during the past decade,
more and more eﬀorts have been devoted to developing the optical imaging technique
toward the early-staged cancer diagnosis. Simultaneously, producing highly eﬃcient
exogenous optical contrast agent for the optical imaging technique has also been
brought up to the calendar. At the beginning, organic dyes such as the toluidine
blue (47) and Lugol’s iodine (48) were the major if not only candidates as optical
contrast agent until the fast developing nano technology brought forward possible
much stronger candidates, namely, the nanoparticles.
Nanparticles could be much more eﬃcient optical contrast agents compared to or-
ganic dyes in that their plasmonic resonance could easily be tuned to be 4 to 5 orders
higher than that of organic dyes. Experimental explorations on engineering nanopar-
ticles to be used for optical imaging procedures have been undergoing for a few years
now (9; 11; 13; 15; 28; 29; 30; 31; 32; 33; 34; 35; 36; 37; 38; 39; 40; 41; 42; 43; 44) and
diﬀerent nanostructures have been tested for such purpose. For example, El-Sayed et
al have used gold nanorods with an aspect ratio of 3.9 as the optical contrast agent
79
for their in vivo cancer cell imaging experiments (9; 33). Loo et al have targeted
the R[60, 10] nm silica-gold nanoshell (nanoshell with a 60nm silica core and 10nm
thick gold shell) with anti-HER2 as the optical contrast agent for in vitro cancer
cell imaging experiments (28; 29; 30). Both groups have reported that the optical
contrasts have been significantly enhanced by nanoparticles.
While experimental investigations “qualitatively” explore the feasibility of using
nanoparticles as exogenous optical contrast agents, it is believed that numerical in-
vestigations could be a useful tool to “quantify” how nanoparticles alter the optical
signatures. By now, for nanoparticle therapeutic application researches, numerical
simulations have already been well recognized as a subsidiary tool for experimental
explorations (1; 2; 3; 49; 50; 51; 52), playing an important role in optimal exper-
iment/therapy plan, or even therapy monitoring. It is therefore quite nature to
expect that for nanoparticle diagnostic application researches, numerical investiga-
tions could play a similar role, providing useful information and insights on how to
engineer nanoparticles to be optimal optical contrast agent for specific imaging pro-
cedures.
Unfortunately, up to now, such researches eﬀorts are extremely rare. To my
information, only Lin and Halas (28) have performed some preliminary numerical in-
vestigations on the interactions of lasers and nanoshells for the benefit of engineering
nanoshells toward disease diagnosis. Their investigation relied on the open sourced
MCML (Monte Carlo modeling of photon transport in multi-layered tissues) package
(53) to simulate laser light propagation within biological tissues, which could only
handle semi-infinite, planar tissue layouts. Another limitation of MCML is that it as-
sumes the laser source is a continuous waved (CW) one while in reality, short pulsed
laser, particularly ultra-short pulsed laser whose radiance lasts from picoseconds to
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nanoseconds are much more preferred for disease diagnosis in that optical signals
that are revolving with time could carry more information of the optical properties
of the tissue medium that the laser lights are traveled within.
Based on such a background, in this chapter, how nanoparticles, specifically,
the silica-gold nanoshell could alter the optical signatures, specifically, the diﬀuse
reflectance signature, of biological tissues would be exploited. In the present in-
vestigation, instead of modeling the laser lights as discontinuous photons using the
stochastic Monte Carlo approach, the laser light propagation was described using the
integral-diﬀerential radiative transfer equation (RTE), which is the alternative and
mathematical equivalence of Monte Carlo light tracing. Also, diﬀerent from what
are for Chapter2, 3 and 4, an ultra-short laser instead of a continuous waved laser
would be used as the optical source.
The goal of the investigation is to explore the feasibility and eﬃciency of nanoshells
as the exogenous optical contrast agent for early-staged cancer diagnosis. Around
this goal, the following problems would be discussed: (1) How nanoshells of diﬀerent
optical properties would aﬀect the diﬀuse reflectance signature; (2) Nanoshells with
what kind of optical properties would make good exogenous optical contrast agent;
(3) How other imaging factors such as the nanoshell concentration, optical properties
of the precancerous tissues and surrounding normal tissues would aﬀect the diﬀuse
reflectance and how these factors could be manipulated toward better imaging.
5.2 Mathematical modeling
For diagnostic applications, short pulsed lasers, particularly, ultra-short pulsed lasers
are much more favored signal sources compared to CW lasers. The reason is that
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the captured optical signatures, namely the diﬀuse reflectance and the transmissity,
from a pulsed laser source would revolve with the time, conveying more information
about the optical properties of the object that is under imaging.
The transient radiative transport equation (RTE) could be used to describe the
interactions between laser lights that emit from a pulsed laser and the turbid tissue
medium that is under imaged:
1
c
BLpr, sq
dt
` BLpr, sqBs ` pkαprq ` ksprqqLpr, sq “
ksprq
4π
ż
4π
Φps, s1qLpr, s1qdω1 (5.1)
Where Lpr, sq indicates the radiant intensity, r and s are the position and direction
vector respectively, c corresponds to the velocity with which laser lights propagate
through the turbid medium, t indicates the time, ω indicates the solid angle, the
kernel Φps, s1q corresponds to the phase function, kαprq and ksprq indicate the local
absorption and scattering coeﬃcient of the medium. If any exogenous optical contrast
agents have been used, kαprq and ksprq should count the influences from both the
tissue medium and the exogenous optical contrast agent:
kαprq “ kα,tissueprq ` kα,exogenousprq (5.2)
ksprq “ ks,tissueprq ` ks,exogenousprq (5.3)
As mentioned above, the silica-gold nanoshell was adopted as the exogenous op-
tical contrast agent. For nanoshells, the absorption and scattering coeﬃcient could
be evaluated using their absorption eﬃciency Qabs and scattering eﬃciency Qsca re-
spectively (1; 2; 3; 49; 50; 51):
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kα,exogenous “ CabsNT “ πr20QabsNT (5.4)
ks,exogenous “ CscaNT “ πr20QscaNT (5.5)
Where Cabs and Csca are the absorption cross section and scattering cross sec-
tion seperately, NT is the number of nanoshells per unit volume and r0 indicates the
radius of the silica core. Notice that for spherical particles such as nanoshells and
nanospheres, Qabs and Qsca could computed using Mie theory (54).
The fundamental idea of using nanoshells as the exogenous optical contrast agent
is that by varying the core radius r0 and core raidus-to-shell thickness, the absorp-
tion cross section Cabs and the scattering cross section Csca of nanoshells are agilely
tunable. And by manipulating Cabs , Csca and NT , kα,exogenousprq and ks,exogenouspr
are controllable, and consequently the overall optical properties kalphaprq and ksprq
could be controlled as well. The goal is to manipulate kαprq and ksprq in Eq. (5.1)
such that consequently a desired distribution of Lpr, sq could be achieved.
Depending on whether any laser lights emitting from a specific position, the
boundary condition for Eq. (5.1) could be written as:
Lbpxb, yb, zb, s, tq “ ￿q0δps´scqδpt´tpq`1´ ￿
π
ż
n¨s1ă0
Lpxb, yb, zb, s1, tq |n ¨ s1| dω1 (5.6)
Where the subscript b indicates the boundary, q0 is the radiant flux of the emit-
ting laser lights, tp is the laser irradiance pulse, ￿ indicates the emissivity of the
boundary and δ is the Dirac delta function.
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Using the discrete ordinate method to discretize the integrals in Eq. (5.1), the
integral-diﬀerential formed Eq. (5.1) could then be represented by a set of partial
diﬀerential equations:
1
c
BLpx, y, z, smn, tq
Bt ` µmn
B
BxLpx, y, z, smn, tq ` ηmn
B
ByLpx, y, z, smn, tq`
ξmn
B
BzLpx, y, z, smn, tq ` pkαpx,y,zqq ` kspx, y, zqqLpx, y, z, smn, tq “
kspx, y, zq
4π
Mÿ
m1“1
Mÿ
n1“1
wm1n1Lpx, y, z, sm1n1 , tqΦpsmn, sm1n1qdωm1n1
(5.7)
Where µmn, ηmn and ξmn are direction cosines of the propagation direction smn
of laser lights:
µmn “ sinpθmqcospϕnq (5.8)
ηmn “ sinpθmqsinpϕnq (5.9)
ξmn “ sinpθmq (5.10)
Notice that the subscripts m and n are the indices for the discretization of polar
and azimuthal angle space respectively, i.e. θm P r0, πs indicates the m-th discretized
polar angel and ϕn P r0, 2πs indicates the n-th discretized azimuthal angel, ωm1n1
indicates the discretized solid angle defined by θm1 together with ϕn1 and wm1n1 is the
weight associated with quadrature. In this investigation, we assume that both the
polar and azimuthal space were divided into M subspaces.
For turbid medium such as biological tissues, Φpsmn, sm1n1q in Eq. (5.6) is usually
represented by the Henyey-Greenstein scattering function:
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Φpsmn, sm1n1q “ 1
4π
1´ g2
1` g2 ´ 2gcospγmn,m1n1q (5.11)
For m,m1, n, n1 “ 1, .....,M
Where g P r´1, 1s is the anisotropy factor, which is an indicator to define whether
a scattering process is forward or backward, i.e., if g ą 0 , then the scattering process
is preferentially forward, if g “ 0 , then the scattering process is isotropic and if g ă 0
, then the scattering process is preferentially backward. For biological tissues, usually
the value of g is usually in the range of r0.7, 1s. Finally, γmn,m1n1 indicates the angle
between the incident direction smn and outgoing direction sm1n1 . Consequently,
cospγmn,m1n1q “ µmn ¨ µm1n1 ` ηmn ¨ ηm1n1 ` ξmn ¨ ξm1n1 (5.12)
The radiant intensity Lpx, y, z, smn, tq in Eq. (5-6) could be split into two parts,
i.e. the attenuated incident radiant intensity Lcpx, y, z, smn, tq and the diﬀuse radiant
intensity Ldpx, y, z, smn, tq induced by Lcpx, y, z, smn, tq :
Lpx, y, z, smn, tq “ Lcpx, y, z, smcnc , tqδrsmn ´ smcncs ` Ldpx, y, z, smn, tq (5.13)
Where δ indicates the Dirac delta function and smcnc indicates the incident di-
rection.
According to the Beer’s law, the incident intensity of laser lights Lcpx, y, z, smn, tq
decays exponentially as the lights propagate within the tissue medium:
Lcpx, y, z, smn, tq “
q0expp´pkpαqpx, y, zq ` kspx, y, zqqzqδrsmn ´ smcncsrHpt´ zc q ´Hpt´ tp ´
z
c
qs
(5.14)
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Where q0 indicates the laser power, Hptq is the Heaviside step function and tp
indicates the laser temporal duration. To simplify the problem, the laser pulse is
assumed to be of the square shaped while for real, the pulses are normally Gaussian
shaped.
Substitute Eq. (5.13) and Eq. (5.14) back into Eq. (5.7) and after some simple
implementations, the expression of the diﬀusion radiation intensity Ldpx, y, z, smn, tq
is derived as:
1
c
BLdpx, y, z, smn, tq
Bt ` µmn
BLdpx, y, z, smn, tq
Bx ` ηmn
B
ByLdpx, y, z, smn, tq`
ξmn
B
BzLdpx, y, z, smn, tq ` pkαpx, y, zq ` kspx, y, zqqLdpx, y, z, smn, tq “
kspx, y, zq
4π
Mÿ
m1“1
Mÿ
n1“1
wm1n1Ldpx, y, z, sm1n1 , tqΦpsmn, sm1n1q`
kspx, y, zq
4π
wmcncLcpx, y, z, smcnc , tqΦpsmn, smcncq
(5.15)
Notice that Eq. (5.15) involves multi scales, for easier implementation, we can
nondimensionalize Eq. (5.15). Define the scaling factors t˚, x˚, y˚, and z˚ as the
following:
t˚ “ pkα ` ksqct (5.16)
x˚ “ xt (5.17)
y˚ “ yt (5.18)
z˚ “ zt (5.19)
After some simple implementation, the scaling version of Eq. (5.15) could then
written as:
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BLdpx˚, y˚, z˚, smn, t˚q
Bt ` µmn
BLdpx˚, y˚, z˚, smn, t˚q
Bx˚ ` ηmn
B
ByLdpx
˚, y˚, z˚, smn, t˚q`
ξmn
B
BzLdpx
˚, y˚, z˚, smn, t˚q ` Ldpx˚, y˚, z˚, smn, t˚q “
ωpx˚, y˚, z˚q
4π
Mÿ
m1“1
Mÿ
n1“1
wm1n1Ldpx˚, y˚, z˚, sm1n1 , t˚qΦpsmn, sm1n1q`
ωpx˚, y˚, z˚q
4π
wmcncLcpx˚, y˚, z˚, smcnc , t˚qΦpsmn, smcncq
(5.20)
Where ωpx˚, y˚, z˚q “ kspx˚,y˚,z˚qkspx˚,y˚,z˚q`kαpx˚,y˚,z˚q is the local scattering albedo.
Correspondingly, the scaling version of the boundary condition equation Eq. (5.6)
is:
Ldpx˚b , y˚b , z˚b , smn, t˚q “
￿q0δrsmn ´ smcncs ` 1´ ￿π
ż
n¨s1ă0
Ldpx˚b , y˚b , z˚b , sm1n1 , t˚q |n ¨ sm1n1 | dωm1n1
(5.21)
and the scaling version of Eq.(5.14) for the attenuated incident radiant intensity
is rewritten as:
Lcpx˚, y˚, z˚, smcnc , t˚q “ q0expp´z˚qrHpt˚ ´ z˚q ´Hpt˚ ´ t˚p ´ z˚qs (5.22)
The solving of Eq. (5.20)-(5.21) requires numerical approximation.
5.3 Results and discussion
In total seven generics of nanoshells have been tested as the exogenous optical con-
trast agent, including the Rr50, 10snm (nanoshells with a 50 nm silica core and
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Figure 5.1: Schematic illustrations: (a) Nanoshells embedded in bulky precan-
cerous tissues; (b) Nanoshells embedded in precancerous tissue that is enclosed by
normal tissues; (c) Nanoshells embedded in precancerous tissue that is enclosed by
normal tissues, nanoshells found in both tissues
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Table 5.1: Optical properties under the wavelength 830nm for nanoshells of diﬀerent
size and core/shell ratio
Nanoshell Types Ext. Eﬀ. Sca/Abs Sca. Eﬀ. Abs. Eﬀ. CSca CAbs
Rr50, 10snm 4.047 0.38 1.11 2.93 8.75E ´ 11 2.30E ´ 10
Rr40, 15snm 2.62 0.701 1.08 1.54 5.43E ´ 11 7.74E ´ 11
Rr55, 25snm 4.4414 3.199 3.38 1.06 3.22E ´ 10 1.01E ´ 10
Rr40, 40snm 3.738 6.27 3.22 0.514 1.62E ´ 10 2.58E ´ 11
Rr75, 40snm 3.7 8.98 3.33 0.371 5.88E ´ 10 6.55E ´ 11
Rr104, 23snm 3.68 3.34 2.83 0.848 9.63E ´ 10 2.88E ´ 10
Rr154, 24snm 4.074 3.132 3.088 0.986 2.30E ´ 09 7.35E ´ 10
a 10nm thick gold shell), Rr40, 15snm, Rr55, 25snm, Rr40, 40snm, Rr75, 40snm,
Rr104, 23snm and Rr154, 24snm nanoshells. Notice that in order to avoid consid-
ering the inter-nanoshell eﬀects, only nanoshells with relative small overall size have
been selected here. Optical properties including the extinction eﬃciency, the ratio of
scattering eﬃciency-to-absorption eﬃciency, the absorption and scattering eﬃciency
and the absorbing and scattering cross section for the seven generics of nanoshells
are listed in Table 5.1. Specifically, the information of extinction eﬃciency and the
ratio of scattering eﬃciency-to-absorption eﬃciency is taken from the reference (55),
based on which the rest information were derived by ourselves through some simple
calculations following Eq. (5.4) and Eq. (5.5). Notice that among all the seven
generics, Rr50, 10snm and Rr40, 15snm nanoshells are preferentially absorbing with
their absorption cross section higher than their scattering cross section while the rest
five generics are all preferentially scattering.
Three phantom models have been covered here: model (a) The laser lights di-
rectly illuminated the precancerous tissue bulk with nanoshells embedded within (as
Fig. 5.1(a) schematically illustrated); model (b) The precancerous tissue bulk was
enclosed from the outside by the normal tissue bulk, nanoshells were assumed to
be confined totally in the precancerous tissue bulk (as Figure. 5.1(b) schematically
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illustrated). Such an assumption only holds when nanoshells show perfect discrimi-
nations between the precancerous tissue and the normal tissue; model (c) The tissue
layout was the same as (b), but nanoshells were found in both the precancerous tissue
bulk and the enclosing normal tissues bulk. However, the nanoshell concentration in
the normal tissue bulk was assumed to be ten times lower (as Figure.5.1(c) schemat-
ically illustrated). The model (c) accounts for situations that nanoshells could not
perfectly recognize the precancerous tissue from the normal tissue. During the recent
few years, reports of in-vivo bio-distribution of nanoparticles(21) kept on emerging,
revealing that nanoshells only show strong discrimination ability for subcutaneous
cancers while for organ cancers including cancers in the liver, spleen, lung and the
kidney, such discrimination ability of nanoshells were noticeable weaker. The model
(c) was therefore specifically targeted for such situations.
The laser lights illuminating the phantoms were assumed to be from a 830nm
ultra-short laser whose pulse persisted during the time range 0 ď t˚ ď 1 and after
the time point t˚ “ 1 , the pulse elapsed. The references (56; 57) have given ranges of
optical properties of precancerous tissues under diﬀerent wavelengths. Based on the
given information, it was assumed that for the wavelength of 830nm, the absorption
coeﬃcient of the precancerous tissues was 0.05 cm´1 , and the scattering coeﬃcient
was 50 cm´1 . And for the enclosing normal tissue in model (b) and (c), the absorp-
tion and scattering coeﬃcient were assumed to be 1.5 cm´1 and 50 cm´1 respectively.
It has been made sure that the optical properties of both the precancerous tissue and
the normal tissues are in the range given in the references (56; 57). For both the
precancerous tissue and normal tissue, the anisotropy factor was assumed to be 0.9
and the refractive index was fixed to be 1.37.
In order to investigate how the nanoshell concentration aﬀects the diﬀuse re-
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flectance signature, the concentration of nanoshells embedded in the precancerous tis-
sue bulk was increased sequentially from 1E9 nanoshells{ml to 1E10 nanoshells{ml
and then to 1E11 nanoshells{ml . Notice that in order to avoid considering the inter-
nanoshell eﬀects, no high concentration values were used here.
Firstly, we discuss how nanoshells alter the diﬀuse reflectance signature in phan-
tom model (a). Since the optical signal was from an ultra-short laser, consequently,
the diﬀuse reflectance signature revolved with the time as well. Fig. 5.2(left) com-
pared the time-revolved diﬀuse reflectance (in absolute value) before and after a
concentration of 1E9 nanoshells/ml nanoshells were embedded in the precancerous
tissue bulk. Fig. 5.2(right) presented the relative alterations in the diﬀuse reflectance
after the adding of nanoshells, computed by dividing the diﬀerences of diﬀuse re-
flectance before and after the addition of the nanoshells by the values of diﬀuse
reflectance before the addition of nanoshells,computed by dividing the diﬀerences of
diﬀuse reflectance before and after the addition of the nanoshells by the values of
diﬀuse reflectance before the addition of nanoshells.
According to Fig.5.2, the diﬀuse reflectance increased monotonously during the
laser pulse duration p0 ď t˚ ď 1q and degrading monotonously beyond the time point
t˚ “ 1 . The degrading was much gradual compared to the increase before t˚ “ 1
, which could be explained by the fact that the precancerous tissue is turbid and
the multi-scattering phenomenon specifically for turbid medium render the diﬀuse
reflectance from decreasing very fast even though the laser pulse elapsed.
Read from Fig.5.2, all seven generics of nanoshells have only altered the diﬀuse
reflectance marginally when the nanoshell concentration was 1E9 nanoshells/ml .
Relatively speaking, when the laser pulse elapsed, the impacts of nanoshells on the
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diﬀuse reflectance were more obvious compared to what was during the laser pulse
duration. Before adding any nanoshells, the diﬀuse reflectance peak was about 0.49.
However, all seven generics of nanoshells diminished the diﬀuse reflectance, at dif-
ferent levels though, despite the fact that five of the seven generics of naoshells are
preferentially scattering with their scattering cross section several times higher than
their absorption cross section.
Particularly, the Rr40, 40snm nanosehll diminished the diﬀuse reflectance the
least (-0.05% „ -0.1%) while the Rr155, 24snm nanoshell diminished the diﬀuse re-
flectance the most ( -1.5% „ -3.2%) . (The numbers inside the parenthesis were the
approximate range of the relative alternations in the diﬀuse reflectance after the addi-
tion of nanoshells, the symbol minus indicates that the diﬀuse reflectance was reduced
by nanoshells) Notice that both the Rr154, 24snm nanoshell and the Rr40, 40snm
nanoshells are preferentially scattering. Particularly, the r154, 24snm nanoshells has
the highest scattering cross section among all seven generics of nanoshells while the
r40, 40snm nanoshell has the lowest scattering cross section among the five generics
of nanoshells that are preferentially scattering. If we rank the nanoshells in the order
of increasing impacts on the diﬀuse reflectance, the ranking would be Rr40, 40snm (
-0.05% „ -0.1% ), Rr75, 40snm (-0.15% „ -0.3% ), Rr40, 15snm (-0.17% „ -0.35%),
Rr55, 25snm (-0.2% „ -0.5% ), Rr50, 10snm (-0.5% „ -1.1%), Rr104, 23snm (-0.55%
„ -1.35%) and Rr154, 24snm ( -1.5 % „ -3.2%).
Fig. 5.3 and Fig. 5.4 presented the time-resolved diﬀuse reflectance and the
relative changes in diﬀuse reflectance when the concentration for the nanoshells was
increased from 1E9 nanoshells/ml to 1E10 nanoshells/ml and then further to 1E11
nanoshells/ml . It was seen that with more nanoshells being embedded, the im-
pacts of nanoshells on the diﬀuse reflectance increased noticeably as well. However,
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two facts remained unchanged: firstly, the diﬀuse reflectance was diminished by
nanoshells, regardless of the nanoshell generics; secondly, the impacts of nanoshells
on the diﬀuse reflectance were more obvious after the laser pulse elapsed.
When the nanoshell concentration was 1E10 nanoshells/ml , the Rr40, 40snm
nanoshells remained to be the generic of nanoshell that diminished the diﬀuse re-
flectance the least (-0.5% „ -1%) percent while the Rr154, 24s nanoshell remained to
be the one that diminished the diﬀuse reflectance the most (-9% „ -20%) . In the or-
der of increasing impacts on the diﬀuse reflectance, the seven generics of nanoshells
could be ranked as Rr40, 40snm (-0.5% „ -1%) , Rr75, 40snm (-1.5% „ -2.2%) ,
Rr40, 15snm (-1.8% „ -3.8%) , Rr55, 25snm (-2% „-4%) , Rr50, 10snm (-4% „ -8%)
, Rr104, 23snm (-4.2% „ -8.2%) and Rr154, 24snm (-9% „ -20%) . It could be seen
that this ranking is the same as what was when the nanoshell concentration was 1E9
nanoshells/ml .
Fig.5.4 however showed something diﬀerent from Fig. 5.2 and Fig. 5.3. Firstly,
it was noticed that for the nanoshell concentration 1E11 nanoshells/ml , nanoshells
have altered the diﬀuse reflectance greatly compared to the previous two nanoshell
concentrations. Secondly, according to Fig.5.4, although the Rr40, 40snm nanoshell
remained to be the one that brought down the diﬀuse reflectance least ( -4% „-
10%), the Rr50, 10snm nanoshell replaced the Rr154, 23snm nanoshell to become the
nanoshell that diminished the diﬀuse reflectance most ( -30% „ -50% ) . Particularly,
notice that the Rr50, 10snm nanoshell was one of the two generics of nanoshells that
are preferentially absorbing with its absorbing cross section being more than two
times higher than its scattering cross section. Rank the nanoshells in the order of
increasing impacts on the diﬀuse reflectance, the ranking was Rr40, 40snm (-4% „-
10%) , Rr75, 40snm (-5 % „ -12%) , Rr55, 25snm (-11% „ -23%), Rr40, 15snm (-12%
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„ -25%), Rr104, 23snm (-16% „ -32%), Rr154, 24snm (-20% „ -40%) , Rr50, 10snm
(-30% „ -50%). Notice that this ranking is very diﬀerent from the rankings when
the nanoshell concentration were 1E9 nanoshells/ml and 1E10 nanoshells/ml .
One existing opinion about using nanoshells as the optical contrast agent is that
nanoshells that are preferentially scattering generally would augment the diﬀuse
reflectance because of the enhancement in scattering they could bring, and since
nanoshells used for such purposes usually have a very high scattering eﬃciency com-
pared to their absorption eﬃciency, it is somehow justified to neglect the absorption
the nanoshells would bring to the tissue medium. What Fig.5.2, Fig.5.3 and Fig.5.4
have presented obviously contradicted this opinion.
Based on Fig.5.2, Fig.5.3 and Fig.5.4, it is analyzed and argued that if using
the nanoshells as the optical contrast agent, whether the diﬀuse reflectance sig-
nature would be enhanced or reduced by nanoshells is not decided by whether the
nanoshells are preferentially absorbing or scattering, or even the scattering eﬃciency-
to-absorption eﬃciency ratio of nanoshells. As Fig.5.2-5.4 have illustrated, nanoshells
that are preferentially scattering with their scattering cross section orders higher
than their absorption cross section are as capable of reducing the diﬀuse reflectance
as nanoshells that are preferentially absorbing. It is suggested based on Fig.5.2-5.4
that after adding the nanoshells to the tissue medium, if the scattering albedo of
the overall medium is higher than the scattering albedo of the precancerous tissue
alone, then the diﬀuse reflectance signature would be enhanced, otherwise it would
be reduced. The more the scattering albedo is altered by adding the nanoshells, the
bigger the impact of nanoshells on the diﬀuse reflectance is.
It is therefore proposed that the modified scattering albedo should be used as the
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index to judge whether the diﬀuse reflectance would increase or decrease by adding
nanoshells, which is formulated as:
ω˚ “ ks,tol
ks,tol ` kα,tol “
ks,tissue ` ks,exogeneous
ks,tissue ` ks,exogeneous ` kα,tissue ` kα,exogeneous (5.23)
And the rule is if
ω˚ ą ω “ ks,tissue
ks,tissue ` kα,tissue (5.24)
Then the diﬀuse reflectance would be enhanced, otherwise, reduced. The bigger
the value of ω˚ ´ ω is, the bigger the nanoshells impact on the diﬀuse reflectance
would be.
In order to verify this argument, the scattering albedo of the overall medium
before and after each generic of nanoshells were added is computed and the changes
of the scattering albedo is listed in Table.5.2(corresponding to nanoshell concentra-
tion 1E9 nanoshells/ml) Table.5.3(corresponding to nanoshell concentration 1E10
nanoshells/ml) and Table.5.4(corresponding to nanoshell concentration 1E11 nanoshells/ml).
It could easily been seen from the three tables. that after adding each generic of
nanoshells, the consequent ω˚ is smaller than the original ω , the higher the nanoshell
concentration is, the bigger the decrease in ω˚ was.
Since the precancerous tissues usually have a very small absorption coeﬃcient,
particularly relative to their scattering coeﬃcient, ω for the precancerous tissue is
usually very high. Therefore, although it is possible to tune the absolute value of
nanoshell scattering cross section to be orders higher than their absorption cross
section, it would still be challenging to engineering nanoshells such that after adding
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Table 5.2: Under the wavelength of 830nm, the overall optical properties of the tissue
medium when the embedded nanoshells concentration is 1E9 nanoshells/ml
nanoshells Overall sca. coef. Overall abs. coef. ω ∆ω
R[50,10]nm 50.0875 0.28 0.994441 -0.00456
R[40,15]nm 50.0543 0.1274 0.997461 -0.00154
R[55,25]nm 50.322 0.151 0.997008 -0.00199
R[40,40]nm 50.162 0.0758 0.998491 -0.00051
R[75,40]nm 50.588 0.1155 0.997722 -0.00128
R[104,23]nm 50.963 0.338 0.993411 -0.00559
R[154,24]nm 52.3 0.785 0.985212 -0.01379
Table 5.3: Under the wavelength of 830nm, the overall optical properties of the tissue
medium when the embedded nanoshells concentration is 1E10 nanoshells/ml
nanoshells Overall sca. coef. Overall abs. coef. ω ∆ω
R[50,10]nm 50.875 2.35 0.955848 -0.04315
R[40,15]nm 50.543 0.824 0.983959 -0.01504
R[55,25]nm 53.22 1.06 0.980472 -0.01853
R[40,40]nm 51.62 0.308 0.994069 -0.00493
R[75,40]nm 55.88 0.705 0.987541 -0.01146
R[104,23]nm 59.63 2.93 0.953165 -0.04584
R[154,24]nm 73 7.4 0.90796 -0.09104
Table 5.4: Under the wavelength of 830nm, the overall optical properties of the tissue
medium when the embedded nanoshells concentration is 1E11 nanoshells/ml
nanoshells Overall sca. coef. Overall abs. coef. ω ∆ω
R[50,10]nm 58.75 23.05 0.718215 -0.28079
R[40,15]nm 55.43 7.79 0.87678 -0.12222
R[55,25]nm 82.2 10.15 0.890092 -0.10891
R[40,40]nm 66.2 2.63 0.96179 -0.03721
R[75,40]nm 108.8 6.6 0.942808 -0.05619
R[104,23]nm 146.3 28.85 0.835284 -0.16372
R[154,24]nm 280 73.55 0.791967 -0.20703
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which, ω˚ ą ω holds.
By now, I have discussed how nanoshells alter the diﬀuse reflectance signature
for model (a), what is about model (b)? The time-revolved diﬀuse reflectance under
diﬀerent nanoshell concentrations for which were presented as Fig.5.5, Fig5.6 and
Fig.5.7. Notice that although the absorption coeﬃcient of the enclosing normal tis-
sue is 20 times that of the precancerous tissue, it is still really small relative to its
scattering eﬃcient. In other words, for both tissues, the scattering heavily dominated
the extinction and the scattering albedo of the normal tissue p0.98q is still really close
in value to that of the precancerous tissue p0.99q . Consequently, before adding any
nanoshells, the diﬀuse reflectance for both models were close to each other.
However, if compare Fig.5.5-5.7 to Fig.5.2-5.4, it could be seen that the impacts of
nanoshells on the diﬀuse reflectance for model (b) were much stronger than what was
for model (a). And due to the nonlinear interactions of the enclosing normal tissue
and the laser lights, it can no longer be simply predicted the impact of nanoshells
on the diﬀuse reflectance by checking the change in the overall scattering albedo
brought by nanoshells. For example, for model (b), when the nanoshell concentra-
tion was 1E11 nanoshells/ml , if we rank the seven generics of nanoshells in the
order of increasing influences on the diﬀuse reflectance, the ranking would be the
Rr40, 15snm (-20 % „ -35%) , Rr40, 40snm (-30% „ -50% ) , Rr50, 10snm (-40% „
-65%) , Rr55, 25snm (-47% „ -70%) , Rr75, 40snm (-58% „-80%) , Rr104, 23snm (-70
% „ -90%) and Rr154, 24snm nanoshells (-85% „ -95%). It could be seen that the
Rr104, 23snm and Rr154, 24snm nanoshells almost diminish the diﬀuse reflectance
to zero. Also it was noticed that the ranking of nanoshells here was not the same
as what was when the nanoshell concentration was 1E11 nanoshells/ml for model (a).
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We now move further to model (c). For this model(c), nanoshell concentration
in the precancerous tissue bulk was assumed to be 1E10 nanoshells/ml and 1E11
nanoshells/ml seperately, and the nanoshell concentration in the normal tissue bulk
was 10 times lower. The time-revolved diﬀuse reflectance for this model was pre-
sented as Fig.5.8 and Fig.5.9. Compare Fig. 5.8 to Fig. 5.6 (for both the nanoshell
concentration was 1E10 nanoshells/ml ) and compare Fig. 5.9 to Fig5.7 (for both
the nanoshell concentration was 1E11nanoshells/ml ), it could be seen the diﬀuse re-
flectance diminished even more in model(c), compared to model (b), induced by the
nanoshells scattered in the normal tissue bulk. However, the impact of the nanoshell
concentration was not as obvious for model(c) as it was for model (b). It could also be
seen that after the nanoshell concentration was increased from 1E10 nanoshells/ml
to 1E11 nanoshells/ml, the transitions of the diﬀuse reflectance was not as obvious
as what was for model (b).
5.4 Conclusions
How gold-silica nanoshells alter the diﬀuse reflectance signature of diﬀerent tissue
phantoms has been numerically investigated for the purpose of exploring how to
engineering nanoshells to be good exogenous optical contrast agent for early-staged
cancer diagnostic imaging. Seven generics of nanoshells were tested including the
Rr50, 10snm, Rr40, 15snm, Rr55, 25snm, Rr40, 40snm, Rr75, 40snm, Rr104, 23snm
andRr154, 24snm nanoshells. Particularly, theRr50, 10snm andRr40, 15snm nanoshells
are preferentially absorbing while the rest five generics are preferentially scattering.
Based on the investigation, it is concluded that: (1) By aﬀecting the scattering
albedo of the overall medium, nanoshells are able to alter the diﬀuse reflectance.
Nanoshells whose optical properties and concentration are such that after adding
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them, the overall scattering albedo is changed dramatically, then it could be expected
that the diﬀuse reflectance would be altered noticeable as well. Particularly, if the
overall scattering albedo is larger than that of the precancerous tissue alone, the dif-
fuse reflectance could be expected to be enhanced, otherwise, it would be diminished.
Since precancerous tissues usually have a very high scattering albedo for the near
infrared spectrum, it would be very challenging to engineering nanoshells such that
after adding them, the diﬀuse reflectance is enhanced. (2) For most real situations,
precancerous tissues are usually embedded within the normal tissue bulk, and if the
cancers are in the organs instead of being subcutaneous, the enclosing healthy or-
gan tissue would retain a certain amount of nanoshells as well. For such situations,
even the conditions related to the nanoshells, including the nanoshell generic and
concentration, are all the same, the optical contrasts induced by nanoshells would
be still be more obvious compared to when the precancerous tissue is bare to laser
lights. In order to count for the nonlinearity of the interactions of the normal tissues,
nanoshells retained by the normal tissues and the laser lights, we strongly suggest
that for such situations, preliminary numerical investigations should be performed
for us to have some insights on how the nanoshells would alter the diﬀuse reflectance
before any real experiments are planned.
5.5 Remarks
This chapter is adapted from:
X. Xu, A. Meade, Jr. and Y. Bayazitoglu, “A numerical investigation of nanoshells
as the exogenous optical contrast agent for early cancer diagnostic, ” in preparation,
2012.
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Figure 5.2: Transient diﬀuse reflectance at the laser emitting face when types
of nanoshells were embedded in bulky cancerous tissues ( absorption coeﬃcient
kα “0.05 cm´1, the scattering coeﬃcient ks “ 50cm´1 ) as the optical contrast
agent. The embedded nanoshell concentration was 1E9 nanoshells/ml
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Figure 5.3: Transient diﬀuse reflectance at the laser emitting face when types
of nanoshells were embedded in bulky cancerous tissues ( absorption coeﬃcient
kα “0.05 cm´1, the scattering coeﬃcient ks “ 50cm´1 ) as the optical contrast
agent. The embedded nanoshell concentration was 1E10 nanoshells/ml
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Figure 5.4: Transient diﬀuse reflectance at the laser emitting face when types
of nanoshells were embedded in bulky cancerous tissues ( absorption coeﬃcient
kα “0.05 cm´1, the scattering coeﬃcient ks “ 50cm´1 ) as the optical contrast
agent. The embedded nanoshell concentration was 1E11 nanoshells/ml
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Figure 5.5: Transient diﬀuse reflectance at the laser emitting face when types of
nanoshells were embedded in cancerous tissues ( kα “ 0.05cm´1, the scattering co-
eﬃcient ks “ 50cm´1 ) which were enclosed by normal healthy tissues p absorption
coeﬃcient kα “ 1.5cm´1, the scattering coeﬃcient ks “ 50cm´1 q as the optical
contrast agent. Nanoshells were found in cancerous tissues only, the nanoshell con-
centration is 1E9 nanoshells/ml
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Figure 5.6: Transient diﬀuse reflectance at the laser emitting face when types
of nanoshells were embedded in cancerous tissues (kα “ 0.05cm´1, the scattering
coeﬃcient ks “ 50cm´1 ) which were enclosed by normal healthy tissues (absorption
coeﬃcient kα “ 1.5cm´1, the scattering coeﬃcient ks “ 50cm´1 ) as the optical
contrast agent. Nanoshells were found in the cancerous tissues only, the nanoshell
concentration is 1E10 nanoshells/ml
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 Figure 5.7: Transient diﬀuse reflectance at the laser emitting face when types
of nanoshells were embedded in cancerous tissues (kα “ 0.05cm´1, the scattering
coeﬃcient ks “ 50cm´1 ) which were enclosed by normal healthy tissues (absorption
coeﬃcient kα “ 1.5cm´1, the scattering coeﬃcient ks “ 50cm´1 ) as the optical
contrast agent. Nanoshells were found in the cancerous tissues only, the nanoshell
concentration is 1E10 nanoshells/ml
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Figure 5.8: Transient diﬀuse reflectance at the laser emitting face when types
of nanoshells were embedded in cancerous tissues (kα “ 0.05cm´1, the scattering
coeﬃcient ks “ 50cm´1 ) which were enclosed by normal healthy tissues (absorption
coeﬃcient kα “ 1.5cm´1, the scattering coeﬃcient ks “ 50cm´1 ) as the optical
contrast agent. Nanoshells were found in both the cancerous tissues and the enclosing
tissue, the nanoshell concentration in the enclosing tissue is 1E9 nanoshells/ml, the
nanoshell concentration in the enclosed cancerous tissue is 1E10 nanoshells/ml
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Figure 5.9: Transient diﬀuse reflectance at the laser emitting face when types
of nanoshells were embedded in cancerous tissues (kα “ 0.05cm´1, the scattering
coeﬃcient ks “ 50cm´1 ) which were enclosed by normal healthy tissues (absorption
coeﬃcient kα “ 1.5cm´1, the scattering coeﬃcient ks “ 50cm´1 ) as the optical
contrast agent. Nanoshells were found in both the cancerous tissues and the enclosing
tissue, the nanoshell concentration in the enclosing tissue is 1E10 nanoshells/ml, the
nanoshell concentration in the enclosed cancerous tissue is 1E11 nanoshells/ml
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6Future work
The research on the medical applications of nanoparticles toward tumor/cancer di-
agnosis and treatment has been ongoing for almost a decade by now. Much related
information, knowledge and learning have been accumulated in this field. Overall
speaking, the decade long research in this field has been very successful and in-
spiring. Many pioneering explorations have been done and many exciting discoveries
have been made, repeatedly confirming the medical potentials of nanoparticles. How-
ever, in my opinion, the most meaningful achievement so far is that the ten years
knowledge accumulation has gradually revealed the underlying core problems and
challenges of pushing forward the biomedical applications of nanoparticles. Only
by facing up to these problems and challenges and finding solutions for them, can
the so-called nanoparticle assisted tumor/cancer diagnosis and treatment really be
pushed from the bench to the clinic.
Based on this present study, I feel the following problems are pending to be an-
swered in order to push forward the research in this field:
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1. To be used as the photo-thermal agent, the absorption spectrum of nanoaprti-
cles plasomonic resonance should be explored and the nanoparticles are engineering
to be such that the absorption heavily dominates over the scattering. When exposed
to the laser exposure, these particles are desired to be point-wise heat source, con-
verting the laser photon energy to thermal heat and transmitting the produced heat
to their surrounding medium very quickly. However, the preferentially absorbing
nature of the nanoparticles most likely would refrain the laser lights from both prop-
agating deep and diﬀusing out(see Chapter 3 and Chapter 4 for more details about
this problem). Therefore, an immediate concern is that whether the refrainments in
the optical transportation could be so strong that current laser delivery techniques
could not guarantee that the intended laser dose could be delivered to the targeted
location. In other words, how to deliver the intended laser dose eﬃciently to the
targeted site, particularly, if the targeted site is relatively deep down from the laser
irradiance beam frontier?
2. In Chapter 5, a preliminary numerical study has been carried out on using
the ultra-short pulse laser and nanoparticles for optical imaging process. The ultra-
short pulse lasers, whose pulses last from picoseconds to nanoseconds, have attracted
much interest and attention of researchers from the optical imaging field during the
recent few years. Optical signals, including the diﬀuse reflectance and the trans-
missivity, induced by the ultra short pulse lasers, are temporal and it is believed
that time revolving optical signals carry more information of the optical properties
of the tissue within which the laser lights propagate through. Although to my infor-
mation, systematic investigations on using ultra short pulsed lasers for nanoparticle
assisted optical imaging procedures have not been reported yet, I believe that such
explorations will be brought to the calendar very soon. Within such a context, it is
natural to pop up the question: Besides being used for the diagnostic optical imag-
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ing, could the ultra-short pulse laser be used for therapies as well? It is worthwhile
to search for the answer of this question because the bio-nano community as a whole
believes that, the most ideal way of applying nanoparticles would be that nanoparti-
cles could perform dual functions as the optical contrast agent for diagnostic imaging
and being the photo-thermal agent for the therapy. Therefore, if it could be proved
that ultra short pulse lasers are feasible power sources for therapies, then, at least
one forward step could be made toward the goal of using nanoparticles dually.
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